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There are still differences of opinion as to whether 
changes in the blood in otherwise normal pregnant women are the 
result of physiological adaptation to pregnancy or a reflection of sub - 
clinical deficiencies of iron and folic acid. 
In some areas the prevalence of overt anaemia due to 
deficiency of iron or folic acid is high. It has been demonstrated that 
these conditions can be almost completely abolished by routine adminis- 
tration of iron and folic acid to all pregnant women. All women, however, 
do not become clinically anaemic in pregnancy. It is therefore reasonable 
to suppose that when routine supplements are given a number of pregnant 
women will receive iron and /or folic acid in excess of the normal require- 
ments. There is little detailed information in the literature on the behaviour 
of iron and folic acid metabolism in such women. 
This project was constructeçl to follow changes in different 
variables of the blood which are related to the status of iron and folic acid 
nutrition in pregnancy. The women studied are all apparently normal, that 
is they have no obvious deficiencies although the presence of sub - clinical 
deficiency may be deduced in thefinal analysis. Comparisons are made 
between women who are able to remain untreated throughout pregnancy, 
women who eventually required treatment, women on iron and women on 
iron + folic acid. Individual results are excluded from the final analysis 
in women who required treatment in addition to that indicated in the original 
protocol. Cases of particular interest, are, however, described in detail 
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in appendix J. 
The results are interesting in that a high proportion of 
pregnant women seem to show evidence of sub - clinical deficiency of iron 
and /or folic acid. There also seems to be a close relationship between 
iron and folic acid metabolism. 
This work is considered to be of value for two reasons: - 
1) The time seems to be rapidly approaching when a 
project of this sort might no longer be considered 
ethical and it is necessary to lose no opportunity of 
increasing our knowledge of normal physiology. 
2) The results demonstrate some features not previously 
noted. These require further investigation to extend our 
understanding of the relationship of iron and folic acid to 
each other and to erythropoeisis and plasma volume changes. 
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'It is quite certain that reproduction is not 
in itself a pathological process, and if 
pregnancy and lactation seem to require 
inevitably routine mass therapeutic measures, 
then we may be sure that something is wrong 
with modern living, or in the interpretation 
of our information. ' Garry and Wood, 1946. 
This observation of Garry and Wood is often quoted, 
but it has to be accepted that anaemia, usually due to iron deficiency, 
is very common in women in this country. It is most prevalent between 
the ages of 15 and 44 years (Kilpatrick, 1961).. This is the reproductive 
period and also a time when iron balance is liable to be precarious because 
of menstrual loss. It has been shown that over a third of normal women 
have a blood loss of 40 ml per month or more which is equivalent to an 
average daily iron loss of more than 0. 6 mg per day (Jacobs & Butler, 
1965). A relatively high prevalence of iron deficiency anaemia persists 
after the menopause and this has been described as a chronic anaemia 
starting during the child- bearing years (Kilpatrick & Hardisty, 1961). 
Routine administration of iron during pregnancy has only 
come into common use in the last 10 or 15 years and is still not universally 
accepted as being of value in normal pregnancy. Hytten & Leitch (1964) 
could find no convincing published evidence that it was an advantage to a 
normal pregnant woman to take extra iron. They agreed with Fisher & Biggs 
(1955) that the real benefit is probably that '....the confidence of both doctor 
and midwife, particularly in domiciliary practise, is greatly increased by 
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by the knowledge that the haemoglobin level is high at term. 
Anaemia, or at least illness which responded to treatment 
with iron, is not a modern disease. Iron was one of the few inorganic 
medicaments described in the early Egyptian pharmacopoeias (Hoppe et 
al 1955). Celsus gave patients with splenomegalic anaemia water in which 
red hot irons had been drenched (D'Arcy & Howard, 1962). Therapeutic 
use of iron in the early centuries was empirical and probably related to 
the association of iron with the god Mars. With the development of 
Christianity the attributes of the gods tended to be transferred to the planets 
of the same name. By the eighteenth century a more scientific approach to 
medicine was developing and in 1746 Menghini showed that the iron content 
of blood could be increased by the ingestion of food rich in irón (Haden, 1938). 
It would seem that severe iron deficiency anaemia was very 
common, particularly in girls at the time of'puberty. This condition was first 
described by Johannes Lange in 1554 in an article entitled 'De Morbo Virgineo', 
(Lancet, 1941) but it was not until 1832 that Fodisch showed that the blood 
of these patients was deficient in iron (D'Arcy and Howard 1962). Chlorosis 
was discussed in Allbut and Rollestons System of Medicine (1912) and was 
described as being almost inevitable at puberty and likely to occur in all 
women at some period of their lives. By 1924 McGowan reported a recent 
decrease in the condition and attributed this to better understanding of diet 
and the nearer approximation of the life of women to that of men. 
Incidental comments made in papers published in the nineteenth 
and early twentieth centuries suggest that in pregnancy blood levels were 
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accepted as normal which would now be looked upon as reflecting 
moderate or even severe anaemia. Willcocks (1881) quotes the haemoglobin 
levels given by Cazeaux in his Traite de l'Art des Accouchements. In a 
normal woman the level was given as 120 g per 1, 000 ml falling to 67.7 per 1, 000 
ml in pregnancy. It is of course, possible that these values are not equivalent 
to modern haemoglobin estimations. Osler (1919) also refers to the 'usual' 
picture of fall in red cells, low haemoglobin and slight leucocytosis in 
pregnancy. It is therefore, not surprising that papers dealing with anaemia 
in pregnancy describe very severe and often fatal cases. It is often difficult 
to interpret the anaemias described in modern terms. Many are related to 
haemorrhage possibly -accentuated by long - standing iron deficiency and others 
with acute sepsis which has no modern equivalent. It is also possible to 
recognise very severe megaloblastic anaemia of pregnancy. These cases 
were usually recognised in the puerperium:although symptoms in late 
pregnancy were often described (Hoskin & Ceiriog- Cadle, 1927). Osier (1919) 
recognised the condition as an Addisionian type of anaemia but unlike primary 
pernicious anaemia in that patients could recover without recurrence. He 
quotes Channing (1842) as being the first to describe the condition. This work 
preceded the classical descriptions of Addison and Biermer. 
Chlorotic conditions of theblood were successfully treated 
with iron during the nineteenth century. In 1832 Blaud introduced treatment 
with pills containing ferrous sulphate and potassium carbonate. At the end 
of the century iron fell into disrepute as a therapeutic agent. Bunge in 1895 
reported that inorganic iron was converted to iron sulphide which was not 
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absorbed from the intestine and Quinke and Van Noorden began to recommend 
very small doses on the assumption that large amounts of iron could not be 
utilised. This proved ineffective and mineral iron by mouth was thought 
to have little value (Haden,.1938). It seems probable that the decrease in 
severe chlorosis at this time reduced interest in iron therapy but it was 
still recommended by the older physicians such as Osier (1919) and Larrabee 
(1925). 
The period between the two world wars was a time when 
the importance of dietary iron was emphasised. The work of Whipple, 
Robscheit and Hooper in 1920, in which they studied artificially induced 
anaemia in animals, was misleading. This was also the time of the 
introduction of the Minot - Murphy diet for pernicious anaemia (1926). It 
was not until 1936 that Witts introduced ferrous sulphate as specific treatment 
in hypochromic anaemia. 
The first quarter of the present century was, however, 
important in that the concept of ante -natal care was established. The first 
pre -natal clinic was established by Dr. J. W. Ballantyne at the Edinburgh 
Royal Infirmary in 1901. Systematic ante -natal care did not begin until 
1911 when clinics were set up in Leeds and Birmingham. It is interesting 
to note that in the controversial literature of the time the advantages put 
forward for the system cite detection of syphilis, toxaemia and mechanical 
abnormalities as being of primary importance. Prevention of anaemia has 
no place except under the general heading of "attention to diet and general 
hygiene. " Treatment of anaemia in pregnancy would seem to have followed 
the same pattern as the treatment of anaemia in the general population as 
it was also in 1936 that Corrigan & Strauss reported the successful 
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treatment of pregnancy anaemia with ferrous sulphate. 
Iron was now accepted as specific treatment for iron - 
deficiency anaemia in pregnancy and, with the work of Moore et al (1945), 
folic acid was established as being specific in megaloblastic anaemia of 
pregnancy. 
The concept of prevention of anaemia in pregnancy by the 
use of routine supplements was a later development although in the case 
of iron this was advised by Hamilton and Wright in 1942. Among others 
Holly in America, Lowenstein and his colleagues in Canada and Giles and 
his associates in this country have been prominent in advocating the 
importance of routine.treatment, begun early in pregnancy, to prevent the 
development of anaemia. In 1964 the British Medical Journal devoted one 
of the series 'Todays Drugs' to a consideration of 'Prophylactic Iron and 
Folic Acid in Pregnancy''. They concluded that iron should be given to 
all pregnant women throughout pregnancy and suggest that if this was 
enforced "much ill! health in middle life would be prevented and vast numbers 
of women saved from leading 'sub -optimal' lives ". They also comment on 
the association of increased incidence of megaloblastic anaemia with severe 
iron deficiency (Chanarin et al, 1965) and recommend that in areas where 
megaloblastic anaemia is common that routine folic acid should be given in 
addition to iron. 
When mineral and vitamin supplements are given it is 
necessary to consider the possibility of toxic effects due to excess. Severe 
reactions with iron are usually associated with the presence of free iron 
in the plasma which is not combined with transferrin. This rarely occurs 
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when iron is given by mouth because of the mucosal block (Iran Toxicity, 
1955). Fatal results are only reported in young children who gain access 
to iron prescribed for adults (Committee on Toxicology report, 1959). 
Minor degrees of toxicity as demonstrated by nausea, vomiting, abdominal 
pain and diarrhoea are not uncommon but these symptoms do not seem to 
occur equally with different iron preparations in any individual. 
There are also possible risks when folic acid is given. 
Very rarely sensitivity reactions are reported (Mitchell et al, 1949; 
Chanarin et al, 1957; Woodliff & Davies, 1966) and Gr4nbaek and Larsen 
(1963) have described the development of polycythaemia vera after two 
months on a large dose of folic acid. The condition resolved itself when 
smaller doses were given. There is also the more important risk of folic 
acid being given as the only medication in a patient who in fact has primary 
vitamin B12 deficiency anaemia. The risk is not great in pregnancy as a 
women with any significant degree of Vitamin B deficiency is unlikely to 
be pregnant. (Todays drugs, 1964). An interesting case is however, 
repo rted by Varadi (1964). A multiparous woman was diagnosed as having 
pernicious anaemia during pregnancy and aborted at 26 weeks. Following 
treatment with vitamin B12 she had a successful 11th pregnancy. 
The risks of ill- effects when routine supplements are given are 
therefore not particularly great when weighed against the positive advantages 
which are the result of prevention of anaemia. In addition to the promotion 
of good health in the mother it has been shown that there is a strong 
correlation between stillbirth rates and maternal anaemia. There is also 
an increased incidence of prematurity (Klein, 1962; Macgregor 1963). 
Folic acid deficiency even when it is not severe enough 
to cause megaloblastosis has been shown to be a disadvantage in pregnancy. 
Martin et al (1965) have described low folate levels associated with recurrent 
abortion. These authors advise treatment with folic acid before the woman 
embarks on another pregnancy. Congenital malformations have been reported 
in folate deficient rats (Nelson, 1960). Hibbard & Smithells (1965) investigated 
the incidence of folate deficiency as shown by a positive Figlu test in women 
who delivered normal infants. There was an incidence of positive Figlu tests 
in 65% of women who delivered malformed infants in contrast to a 17% incidence 
in the paired controls. Hourihane et al (1960) and Hibbard & Hibbard (1963) 
have also described an increased incidence of abruptio placentae in women 
with folic acid deficiency. 
Many people are, therefore, in favour of giving supplements 
of iron with or without additional folic acid to all pregnant women. It there- 
fore becomes important to study the effect of these supplements on apparently 
normal women. It is also desirable to discover what proportion of women do 
not need protection against sub - clinical or frank deficiency and whether it is 
possible to identify such women early in pregnancy. More information is 
also needed on the effect of iron in excess of normal requirements on the 
physiological adaptation to pregnancy. There is also insufficient information 
on the way in which additional folic acid will modify the effect of iron. 
In the presentation which follows volume changes and the 
status of iron and folic acid nutrition are studied in the absence of treatment 
and in relation to treatment with iron or with iron and folic acid. 
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Chapter 2 
Materials and Methods 
Patients Studied 
The women who took part in the investigations wer e patients with 
a haemoglobin level above 10. Og% who attended the booking clinics at 
the Maternity Hospital, Glossop Terrace, Cardiff before the 20th week 
of pregnancy. These women were interviewed to explain the object of 
the investigation and the procedures which would be involved. They were 
then asked if they would co- operate. 
Patients were recruited for the project between December 1962 
and October 1963, during which time there was a considerable amount of 
publicity with reference to foetal malformations following the administrat ion 
of thalidomide in early pregnancy. It seems probable that this explains the 
unexpectedly high refusal rate which was 39% of the women seen. A further 
18% were excluded for medical reasons. 
During the period March 14th -October 18th, 1963, a detailed record 
was kept of the medical reasons for exclusion and also the reasons given 
by patients to justify their refusal. Three hundred and twenty -eight women 
were seen during this period and 61 were excluded for various causes among 
which urinary infection and threatened miscarriage were the commonest. 
A further 127 women refused to take part; in 36 cases either the husband or 
wife objected and in 49 cases this was expressed as "family difficulties. " 
(Appendix A, Volume 2, Page 2). At the commencement of the work 
it was found that objections to the investigation most commonly came 
-13- 
from the husband. An explanatory letter was therefore prepared for 
the wife to take to her husband and there was little further trouble. 
A copy of this letter is included in the pocket at the back of Volume 2. 
There was no significant difference in a ge or parity between 
those who entered the investigation and those who did not (vol. 2 p. 15) 
but one gained a strong clinical impression that those who agreed to 
co- operate were more intelligent and that many were from the higher 
social classes. 
Patients who entered the investigation were placed in one of 
three groups. The method of selection was worked out by Dr. Lewis 
Fanning on a statistical basis to ensure an even spread of women with 
regard to age, parity and initialhaemoglobin level. The first group 
received iron in the form of ferrous sulphate 194 mgs. (61 mgm. 
elemental iron) twice daily after meals. In the case of the second 
group the ferrous sulphate tablets also contained 1. 7 mgm /folic acid; 
these were also given twice daily. The third group were initially 
untreated. The tablets in the trea ted groups were identical in 
appearance and were made up in numbered bottles to correspond with 
the numbers allotted to the patientsin the trial. The code was not 
disclosed until the end of the investigation. It was decided not to give 
the untreated group a placebo as it seemed preferable to know which 
women were untreated so that there would be no delay in starting 
therapy if this became necessary. In all cases treatment was 
discontinued after delivery. 
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Two hundred women entered in the investigation, 68 on iron, 68 
on iron and folic acid and 64 untreated, but only 154 were followed 
through to the post -natal visit. The groups remained evenly divided 
(iron 49, iron and folic acid 51, untreated 54) and there was no significant 
difference between the groups for age, parity or initial haemoglobin 
level (vol. 2 p. 15). 
Eight women were excluded for medical reasons such as 
confusion over therapy, intercurrent illness and difficult veins. Six 
were possibly intolerant to imferon but their discomfort could well 
have been nervous in origin. Oneiwoman had a definite reaction to 
imferon at the second blood volume estimation (see Appendix J). 
Among the remaining 31 who failed to complete the investigation, 5 
miscarried or went into premature labour, 11 were intolerant of the 
form of iron used and fifteen failed to attend. (vol. 2, p. 3). 
Patients entered the investigation at 16 weeks or 20 weeks and in 
all patients, haemoglobin and haematocrit estimations were done and a 
blood film examined at monthly intervals throughout pregnancy and also 
at the post -natal visit 6 -8 weeks after delivery. The blood film was 
assessed for evidence of anaemia and a mean lobe count made on 100 
polymorphonuclear leucocytes. In addition the percentage of polymorpho- 
nuclear leucocytes with 5 or more lobes was noted. Serum iron and total 
iron binding capacity were also estimated on all patients at 20 weeks 
28, 36 and 40 weeks and at the post -natal visit. 
Serum B12 and serum folate estimations were made on half of 
the women in each of the 3 main groups at monthly intervals from 16 or 
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20 weeks (dependant on the time of entering the investigation). While 
in the other half, blood volume estimations were made at 20, 28, 36 
and 40 weeks. The investigations were repeated in both sub -groups at 
the post -natal visit When the blood volume was estimated, extra serum 
was collected at 20 weeks, 36 weeks and post -natally. This was stored 
at -20oC until the three specimens were obtained and then protein 
electrophoresis strips were run simultaneously. 
It will therefore be seen that the women studied form six 
sub - groups identified as groups ,1 to 6 depending on the treatrre nt given 
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Serum B12 & Folate. 
B. V. 
Serum B12 & Folate. 
B. V. 
Serum B12 & Folate. 
Tables showing the detailed results of each investigation 
on all of the women are given in the appendices in Volume 2. The groups 
are identified by the numbers as shown above. 
When the results were studied at the end of the investigation 
it was found that only 16 (30 %) of the untreated group remained completely 
untreated throughout the pregnancy. This meant that there WQ,Zßin fact 
four groups to consider instead of the three groups of the original 
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protocol. These are shown below with the number of patients in each 
group and the lettered code by which they were identified. 
I Iron 49 Blood volume 20 
Serum B12 & folate 29 
I +F Iron + Folic Acid 51 Blood volume 
Serum B12 & folate 
24 
27 
Cu Completely Untreated 16 Blood volume 8 
Serum B,12 & folate 8 
Cw Patients requiring 38 Blood volume 17 
treatment while 
untreated. Serum B12 & folate 21 
Patients in the Cw group were excluded after beginning treatment 
and none remained after 38 weeks. 
In comparison with other workers in this country 30% represents 
a low rate of salvage for a control group. Chisholm (1966) in a similar 
investigation needed to treat 35 of 177 women (20 %) who were initially 
given a placebo instead of iron. Her investigation, however, did not 
start until 28 weeks and 50 women were excluded from the study as 
already showing evidence of anaemia. Chanarin et al (1965) found that 
10 women in a control group of 52 (19 %) required iron therapy. My own 
figure is closer to that of Holly (1955) who considered that as many as 78% 
of women will develop at least mild iron deficiency anaemia during 
pregnancy if untreated. 
The differences, to some extent, are explained by the criteria used 
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to decide when treatment becomes necessary. It was originally intended 
not to give iron therapy in the untreated groups until the haemoglobin level 
fell below 10. 0 g%. In practice it was found that treatment was started at 
11. 0 g% and because of the method of haemoglobin estirm tion used (see 
below) the final reading, taken after the patient had left, was often above'; 
this figure. 
It would in fact have been difficultnd to treat these women as they 
took a great interest in the investigation and in their haemoglobin levels 
and were anxious that nothing should be done, or left undone, to prejudice 
the foetus. Complaints of fatigue and general lack of wellbeing were common 
in this group and improved when they were given oral iron. This might 
reflect lack of iron stores as described by Holly (1965) and Fielding et 
al (1965). Beutler and his co- workers (1960) showed that symptoms were 
relieved when iron was given to women with normal haemoglobin concentrations 
but with no evidence of stored iron as shown by examination of the marrow. 
Jennison and Ellis (1954) also reported resolution of symptoms in cases of 
iron deficiency anaemia within a few days of starting treatment and before 
the haemoglobin concentration began to rise. The more recent work of 
Elwood and Wood (1966) does not confirm this. Iron or a placebo was given 
to women with a haemoglobin of more than 10. 0 g %;and although there was 
a significant rise in haemoglobin level in patients on iron, there was no 
convincing evidence of an improvement in any symptom. A preliminary 
analysis of a further study on women with symptoms of '-chronic fatigue" 
and haemoglobin levels of more than 13.5 g% suggests that iron gave no 
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greater benefit than a placebo (Elwood 1967, personal communication). 
It is therefore accepted that a proportion of the women in the Cw 
group were at most only slightly anaemic and it seems likely that if placebo 
tablets had been given more women would have remained untreated. 
The Cu group, however, now consists of women, who from the 
haematological point of view, probably approximate much more closely 
to the ideal of normality than is usual in most control, groups in the 
literature. 
Methods 
The methods used in the various investigations are outlined and 
discussed here but full technical details are given in Volume 2, Appendix 
I. 
Haemoglobin was estimated in triplicate, using capillary blood, 
by the alkaline - haematin method as modified by Dr. J. L. Withey 
(unpublished). A preliminary reading was available at the time when the 
patient was seen at each visit, but for purposes of the study the level given 
after the alkaline - haematin mixture had stood for 15 minutes was used. 
The mean value for the three specimens was taken. 
Capillary blood was also used to estimate the haematocrit 
by means of the Hawksley micro- centrifuge. Estimations were again 
made in triplicate and the mean taken. 
The mean corpuscular haemoglobin concentration was calculated 
from the haemoglobin and haematocrit readings. 
Blood films were made directly from capillary blood and 
stained with Leishman's stain. The films were assessed as being 
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normochromic or hypochromic, normocytic, microcytic or macrocytic 
and for the presence of absence of poikilocytosis and polychromasia. 
The number of lobes in 100 polymorphonuclear leucocytes was counted 
and the mean taken. The nuDnber of polymorphonuclear leucocytes with 
2, 3, 4, 5 and 5+ lobes was also noted and a general impression of the 
appearance of the film given. 
Bone marrow was only examined when necessary for diagnostic 
purposes and on these occasions sternal puncture was done. 
Serum B and serum folate estimations were done in the 
12 
Welsh National School of Medicine, Department-of Pathology by courtesy 
of Dr. J. L. Withey. 
Serum B. was assayed with euglena gracilis (Z strain) using 
a method mofified from Ross (1952) and Hutner et al (1956). Normal range 
120 -650 piagm /ml. 
Serum folate was assayed using the lacto- bacillus casei method 
of Waters and Mollin (1961). Normal range 2. 1 -20 mpg /ml. 
A micro - method for the determination of serum iron and total 
iron binding capacity was devised for the purpose of this investigation in 
collaboration with Dr. D. K. Watkins (Watkins and Butler 1966). The process 
made use of a scaled down and slightly modified version of the method 
described by Henry et al (1958) for unsaturated iron binding capacity. 
The micro -method for serum iron estimation was also applied 
in the plasma volume studies as the estimations were made by injecting the 
iron dextran complex "Imferon ". (Butler and Watkins 1966). 
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It was fully appreciated that the most accurate method for 
neasuring blood volumes are those in which plasma and red cell volumes 
Ire estimated individually. Estimations of red cell volume, however, involve 
he use of radio - active tracers such as 51Cr. (Gray and Sterling, 1950; 
3trumia et al 1958) or 32P (Reave and Veal 1949; Verel et al 1956), and 
although this has been done in pregnancy (Paintin 1963 and Pritchard 1965) 
.t seemed preferable not to risk the possible effect on the foetus. 
The use of Evans Blue (T -1824) (Gibson and Evans 1937; Mollison 
1961) is a well established method of plasma volume estimation, but as serum 
.ron estimations were already being performed, it seemed to be an advantage 
iot to increase the number of procedures to be perfected by a limited technical 
Staff. 
The use of Imferon to estimate plasma volume was first described 
)y Scott (1956) and was later used by Mackenzie and Tindle (1959). The method 
zsed in this study differed from that described by the previous authors in that 
he amount of Imferon given was reduced to the equivalent of 20 mgm of elemental 
.ron compared with 100 mgm given by Scott (1956) and 50 mgm given by 
Mackenzie and Tindle (1959). 
Blood volumes and red cell volumes were calculated making use 
)f the haematocrit reading. It is now universally accepted that the venous 
zaematocrit differs from the true body haematocrit calculated from plasma 
Tolume and red cell volume by about 10 %. This is because there is a higher 
)roportion of plasma to red cells in smaller blood vessels than in larger blood 
vessels (Fahreus 1929). The ratio between body haematocrit and 
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venous haematocrit is called the haematocrit ratio. The mean haematocrit 
ratio was shown to be constant in non -pregnant individuals. It was calculated 
as 0. 91 by Gibson and his co- workers (1946) and also by Chaplin et al (1953) 
Gibson et al estimated red cell volume using cells labelled with either 55Fe 
or 59Fe while Chaplin and his colleagues used red cells labelled with 32P. 
Both groups estimated plasma volume using Evans Blue. Caton and his 
colleagues (1951) repeated this work in pregnancy, estimating plasma volume 
with Evans Blue and red cell volume with cells labelled with 55Fe, but they 
found that the haematocrit ratio varied and came close to unity as term was 
approached. Similar results were reported by Verel et al (1956). These 
findings have not been confirmed by recent work. Pritchard and Rowland 
(1964) used 1311 albumen to estimate plasma volume and 51Cr tagged red 
cells to estimate red cell volume. They found themean haematocrit ratio 
to be 0. 89 in non -pregnant women, women in late pregnancy and also 48 hours 
after delivery. Similarly Paintin (1963) using Evans Blue and 51Cr tagged 
red cells found that the haematocrit ratio was sufficiently constant during 
pregnancy to be used to calculate total blood volume and red cell volume from 
observed plasma volume. The mean haematocrit ratio in Paintin's series 
was given as 0. 88 and this figure was used for the purpose of the present 
project. 
In earlier work on blood volume estimations it was also considered 
necessary to correct the haematocrit for trapped plasma,. but in this study 
haematocrit readings were done using the Hawksley micro - centrifuge 
(12, 000 g for 5 minutes) and this correction was not considered to be necessary 
(Paintin 1963). 
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It was however, found that there was liable to be a fall in the 
haematocrit readings, of up to 2% in some women, between the specimens 
taken before and after giving Imferon. Preliminary work indicated that the 
variations were individual and were associated with posture (Mollison 1961). 
It was not possible to arrange for the women to rest for 30 minutes in a warm 
bed before making the blood volume estimations although this would probabl y 
have eliminated the difficulty,. (Paintin 1962). The estimations had to be made 
when patients attended the ante -natal clinic. Haematocrit readings were 
therefore taken before giving Imferon and also on the post -Imferon specimen. 
When there was a change in the haematocrit, the plasmalvolume was corrected 
to that corresponding to the first result, assuming that the red cell volume was 
constant throughout (Butler and Watkins' 1966.) 
Blood volume estimations were made throughout pregnancy and at 
the post -natal visit on 52 women. In 38 of these cases additional blood was 
taken at 20 weeks, at 36 weeks and at the post -natal visit for protein electro- 
phoresis. The serum was separated and stored at -20 °C until the group of 
specimens for each patient was complete. They were then run simultaneously. 
The method used was that of Sammons and Whitehead (1963). 
The intention was to compare the changing pattern of the protein 
fractions between the middle and end of pregnancy. It was therefore thought 
to be suficient to express the albumen and globulin constituents as a 
percentage of the whole and total protein was not estimated. 
All specimens were taken when patients attended the ante -natal 
clinics so that there was no uniformity in the time of day at which specimens 
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from different women were taken but there is reasonable uniformity between 
the successive specimens from individuals. 
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Chapter 3 
Observations: 1. Haemoglobin Concentration and Iron Metabolism 
The results of the investigation will be described and discussed 
in the next three chapters. Comparisons will be made between four 
groups of women:- 
Patients on Iron I 
Patients on Iron + Folic Acid I +F 
Completely Untreated Cu 
Requiring treatment while untreated Cw 
The variables are considered at 20, 28, 36 and 40 weeks and 
also at the post -natal visit 6 -8 weeks after delivery. The mean values 
for each group are compared and also in most instances the mean regression 
co- efficient during pregnancy (post -natal readings were excluded). Where 
relevant Fisher's method for combining significance levels from different 
samples is also applied. 
RESULTS 
Haemoglobin Concentration (Vol. 2, p. 16 and Figure 1). 
Mean Values and Range (: g% ) 
(Number of estimations in brackets) 
Weeks I I +F Cu Cw 
20 12.6 (49) 12.4 (51) 12.5 (16) 12.1 (38) 
11.2. -1.4', 8 10.4 -14.2 11.3 -14.2 10.2 -13. 6 
28 12.6 (49) 12.4 (51) 12.5 (16) 11.8 (25) 
10.5 -14.7 10.1 -14.4 11.6 -13.8 10.1 -12. 9 
Fig. 1. Haemoglobin; Scattergrams and 
Mean Values 
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Weeks I I F Cu :; Cw 
36 13.1 (48) 12.9 (49) 12.6 (16) 11.8 (9) 
10.4 -14.8 10.1 -14.8 11.8 -13.9 10. 7 -12.4 
40 13.6 (27) 13.3 (33) 13.5 (6) 
11.0 -15.4 10.7 -14.8 12.4 -14.4 
PN 14.0 (49) 13.9 (51) 13.8 (16) 
12.1-15.7 12.3-16.0 12.1-14.7 
Hb. 
Cw 
was significantly lower at 20 weeks than Hb1 (p<0. 005), 
Hb.I +F (p < 0. 02) and HbCu (p (0.05). It was also not surprising that at 
28 and 36 weeks HbCw was again significantly lower than the Hb. concentration 
in the other groups. In addition at 28 weeks Hbl was lower than Hbl 
(p <0. 05) and at 36 weeks HbCu was lower than HbI (p(0. 05).: There 
were no significant differences between mean Hb. concentrations in the 
I, I +F and Cu groups at 40 weeks or at the post -natal visit. 
Linear regressions were studied'in the I, I +F and Cu groups. 
The mean regression co- efficient was positive in each of them but was 
higher in the treated groups than in the completely untreated. 
(I vs Cu: p < 0. 05, I +F vs Cu: p<0.05). 
Haematocrit. (Vol. 2, p 23). 
Mean values and Range ( %) 
(Number of estimations in brackets) 
Weeks I I +F Cu Cw 
20 36 (49) 36 (51) 36 (16) 35 (38) 
31 -43 31 -40 33 -40 30 -40 
28 36 (49) 35 (51) 36 (16) 35 (25) 
31 -43 29 -40 33 -38 33 -39 
+ Excluding one patient (Hb. = 13.1 g %) who started treatment following 
Delivery because of heavy blood loss. 
Mean value in the group indicated. 
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Weeks I I + F Cu Cw 
36 38 (48) 37 (48) 37 (15) 35 (9) 
30 -44 32 -44 33 -41 33 -40 
40 39 (26) 38 (33) 39 (6) 
32 -42 32 -42 35 -43 
PN 49 (49) 40 (51) 39 (16) 
34-45 35-44 35-42 
The mean haematocrit level in the Cw group at 20 weeks was 
significantly lower than in the I t group (p0. 02) or the Cu group (p(0. 02). 
This difference was again noted at 28 weeks (p ('0. 002). In addition at 28 
weeks the mean haematocrit in the I +F group was significantly lower than 
in the I -group (p<0.02). At 36 weeks Haematocrit 
Cw 
was significantly 
lower than the Haematocrit (pK0. 02). The mean values at 40 weeks were 
of interest as Haematocritl 
+F 
was lower than Haematocritl at the 5% level 
of significance. No significant diferences were found between the mean 
post natal readings. 
The mean regression co- efficient was pGsitive in the three groups 
studied and was significantly higher in the group on Iron than in the completely 
untreated group4p <0. 0005). F It was also higher in the group on Iron + 
Folic acid than in the completely untreated group (p<0.05). 
Mean Corpuscular Haemoglobin Concentration (Vol. 2, p. 30) 
Mean Values and Range ( %) 
(Number of estimations in brackets) 
Weeks I I + F Cu Cw 
20 35.1 (49) 34.9 (51) 34.3 (16) 34.8 (38) 
31.1 -38.7 31.0 -39.0 32.7 -36.5 31.4 -37.7 
28 34.8 (49) 34.8 (51) 34.5 (16) 34.2 (25) 
31. 5 -38.0 31. 0 -38.7 32i 5 -35.7 31.5-37.0 
Fig. 2. Serum Iron; Scattergrams and Mean Values 
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Weeks I I+F Cu Cw 
36 34. 7 (48) 34.4 (48) 34.5 (15) 33. 2 (9) 
31. 2-39.3 32. 3 -39. 0 33. 0 -36. 5 29.0 -35. 5 
40 35.1 (26) .35.2 (33) 34.4 (6) 
31.2 -38. 6 32.5- 37.3 32.5-35.5 
PN 35.0 (49) 35. 1 (51) 34.9 (16) 
31. 5-38. 3 31.2 -38.4 33. 2 -36. 3 
MCHCCu was lower than MCHCI at 20 weeks (p <0. 05). 
There were no significant differences between any of the mean values 
'at 28 weeks. At 36 weeks MCHCCw was significantly lower than MCHC 
(p < 0. 01) and then MCHCI (p < 0. 002). No significant differences were 
noted between the mean values at 40 weeks or at the post natal visit. 
The linear regressions were near to zero and showed no 
significant differences. 
Serum iron (Vol. 2, p 37 and Figure 2). 
Mean Values and Range (1u.gms %) 
) (Number of estimations in brackets) 
Weeks I I+F k Cu Cw 
20 97.5 (48) 88.1 (49) 106.9 (16) 80. 6 (38) 
39.4 -184. 0 25. 0 -176. 0 50. 5 -202. 0 35. 7 -168. 5 
28 110.2 (48) 109.2 (50) 88.2 (15) 78. 2 (24) 
27.0 -246. 0 39.4 -270. 0 63. 0 -146. 0 39.4 -176. 0 
36 118.3 (45) 115.6 (48) 78.5 (15) 78. 2 (9) 
54. 0 -232. 0 49. 0 -331. 0 37. 0 -150. 0 54.0 -135.0 
40 124.4 (26) 127.8 (32) 109.8 (5) 
60. 5 -319. 0 56. 5 -215. 0 91. 0 -125. 0 
PN 101. 8 (47) 100.9 (50) 100.7 (16) 
40. 6-157. 5 39. 4-19 9. 0 50. 5 -169. 0 
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At 20 weeks Serum IronCu was significantly higher than 
Serum Ironl (p < 0. 002), Serum Ironl+F (p < 0. 05) and Serum Iron 
Cw 
(p < 0. 005). The mean value in the group which would require treatment 
was also significantly lower than the mean value of the group on Iron 
(p <0. 01). The mean serum iron levels at 28 and 36 weeks, were 
significantly higher in the groups receiving treatment (with the exception 
of I +F vs Cu at 28 weeks) than in either of the untreated groups:- 
28 weeks 
36 weeks 
I vs Cu 
Ivs Cw 
I+F vs Cw 
I vs Cu 
I+F vs Cu 
Ivs Cw 
I+F vs Cw 
(p<0. 02) 
(p <0. 0005) 
(p<0. 002) 
(p <0. 0005) 
(p<0. 01) 
(p(0. 005) 
(p <0. 05) 
There were no signficant differences at 40 weeks or at the 
post natal visit. 
The mean regression co- efficient was positive in both of the 
treated groups and negative in the completely untreated group, These 
differences were hightly significant (I vs. Cu, p(0. 002 and I +F vs Cu, 
p <0. 0005). The positive linear regressions were also significant as 
judged by Fisher's test in both of the treated groups (p< 0. 01). 
Total Iron Binding Capacity (Vol. 2 p. 44 and Figure 3). 
Mean Values and Range (pgms %) 
(Number of estimations in brackets) 
Weeks 
Fig. 4. Latent Iron Binding Capacity. Scattergrams and 
Mean Values 
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Weeks I I +F Cu Cw 
20 343. 8 (48) 294. 7 (49) 290.4 (16) 294.4 (38) 
156. 5-586. 0 123.4-548. 5 139. 5-438. 0 172. 0-458. 0 
28 345.2 (48) 336.8 (50) 341.7 (15) 331.9 (24) 
192. 0-590. 0 156. 5-782. 5 236.5-512. 0 143. 0-588. 5 
36 393. 1 (45) 378. 1 (48) 377.4 (15) 429.3 (9) 
182. 0-790. 0 211. 5-699. 0 179.8-604. 5 261. 0-565. 0 
40 366. 8 (26) 413.5 (32) 394. 8 (5) 
230. 0-580. 0 222. 0-631. 0 262. 0-568. 0 
PN 305.5 (47) 305.7 (49) 347.1 (16) 
206. 5 -475. 5 183. 0 -509. 0 204. 0 -497. 0 
The only significant difference between the mean values at the 
weeks studied was between the I and I +F groups at 20 weeks (p (0. 025). 
Total iron binding capacity, however, was the only variable which did not 
show uniformity on the Chi - square distribution at 20 weeks (vol. 2, p. 15). 
The mean regression co- efficient was positive in the three groups 
tested and the rise was significant by Fisher's test (I:p(0. 025, I +F: p Q0. 005. 
Cu: p <0. 05). There were no significant differences between the groups. 
Latent Iron Binding Capacity (Vol. 2, p. 51 and Figure 4). 
Weeks I 
Mean Values and Range (}igms %) 
(Number of estimations in brackets) 
I + F Cu Cw. 
20 246.1 (48) 206.6 (49) 183.5 (16) 215.1 (38) 
96.0 -500.0 81.4 -465.0 89.0 -310.0 96.0 -384.0 
28 235. 4 (48) 227. 6 (50) 253.4 (15) 253. 7 (24) 
74. 0 -525.0 44. 5 -695.0 170. 0 -420.0 87. 5. -516. 0 
36 274.1 (45) 262.4 (48) 298.7 (15) 351.1 (9) 
96. 0 -614. 0 81. 0 -650 -0 133. 0 -650. 0 192. 0 -486. 0 
Fig. 5. % Saturation; Scattergrams and Mean Values 
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Weeks I I +F Cu Cw 
40 242.4 (26) 285.7 (32) 285.0 (5) - 
81. 0 -405.0 103.0-509.0 148.0-443.0 
PN 203.7 (47) 205.3 (49) 246.4 (16) - 
88.5-399.0 66.5-370.0 102.0-394.0 
The mean latent iron binding capacity at 20 weeks was lower 
in the Cu group than in the other groups. This difference was significant 
when the comparison was made with the I +F group (p<0. 02). The only 
other significant difference between the mean values at the weeks studied 
was at 36 weeks when the group requiring treatment showed a higher mean 
value than the other groups. This was significant in the comparison 
1 +F vs Cw (p <0. 025). 
Percentage Saturation (Vol. 2, p. 58 and Figure 5). 
Weeks I 
Mean Ralues and Range (To) 
Cw I +F Cu 
20 29.5 (48) 31.0 (49) 37.0 (16) 28.3 (38) 
13.5-50.0 13.9-53.0 22.0-56.5 9. 7 -48. 0 
28 33.4 (48) 34.1 (50) 27.2 (15) 25.7 (24) 
9. 7-67.0 9. 9- 71.5 14. 5 -46.0 11.5-52.0 
36 32.7 (45) 31.8 (48) 21.8 (15) 18.6 (9) 
9.6-63.6 7.0-80.0 8. 0 -47.0 11.2-26.0 
40 35.2 (26) 32.4 (32) 29.4 (5) 
14.3-78.3 14.5-60.6 22.0-43.5 
PN 35.4 (47) 33.7 (49) 29.7 (16) 
15.0-60.0 16.5-75.0 18.8-57.5 
The mean value of the Cu group at 20 weeks was higher than 
the mean values in the other groups. The difference was significant 
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when the comparison was made with the group on Iron (p (0. 01) and 
with the Cw group (p (0. 005). At 28 weeks % Sat. was significantly 
lower than % Sat. or % Sat. +F (p( 0. 02). As would be expected, at 36 
weeks the mean % saturation in the treated groups was significantly 
higher than in the untreated groups 
I vs Cu (p (0. 005). 
I +F vs Cu (p (0. 01) 
I vs Cw (p(0. 005) 
I +F vs Cw (po. 01) 
No significant differences were noted at 40 weeks or at the 
post natal visit. 
DISCUSSION 
Haemoglobin Concentration 
It is generally accepted that the haemoglobin concentration 
in pregnancy does not necessarily reflect the presence or absence of 
anaemia (Scott, 1962). 
Willcocks (1881) recognised the occurrence of hydraemia in 
pregnancy due to the vascular system becoming filled with "fluid of liquor 
sanguinis "Lwhile the number of red cells remained constant. These 
views were confirmed when it became possible to estimate plasma volume 
(Dieckman & Wegner, 1934; Gibson & Evans, 1937). 
Later observers showed an inverse relationship between 
haemoglobin levels and plasma volume during pregnancy. Lowest levels 
of haemoglobin concentration were found at the time of greatest plasma_volume 
increase, that is between 28 and 36 weeks. Haemoglobin levels rose slightly 
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towards term (Evans, 1943; Scott and Govan, 1949; Giles and Burton, 
1960) at which time most workers reported a fall in plasma volume 
(Lund 1951; Cope 1958). The term "physiological anaemia" was used 
to describe this condition of the blood in pregnancy and only levels below 
10.0 g/100 ml were considered abnormal (Whitby & Britton 1953). In 
America Holly (1960) placed the level higher at 11.5 g/100 ml. 
The concept of physiological anaemia has been questioned in 
recent years since it has been shown t at when iron was given during 
pregnancy the fall in haemoglobin concentration could be corrected 
(Scott & Govan 1949; Kerr & Davidson, 1958). In addition treated cases 
showed a higher haemoglobin level after delivery (Verloop et al 1959). 
Recent writers have advised routine iron in pregnancy and have considered 
that a haemoglobin concentration of at least 11.8 g/100 ml should be 
maintained (Giles & Burton 1960). 
Pregnancy is, however, a physiological state and one would 
expect a normal woman, on ainormal diet, to adjust to it without mineral 
supplements. Hamilton (1950) has shown that haemodilution, by causing 
a relative decrease in cell elements, reduces blood viscosity and that this 
is associated with increased cardiac output. Relative increase of plasma 
volume also permits greater loss at delivery without the untoward effects 
which are seen when an equivalent rapid blood loss occurs in the non - pregnant. 
The Cu group in the present study is of great interest in that they 
showed no evidence of anaemia. In this group the lowest mean haemoglobin 
level had been reached by 20 weeks. Analysis of results was begun at 20 weeks 
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as it was not possible to recruit sufficient women by 16 weeks. Results 
for a proportion of the patients, however, were available for this earlier 
stage of pregnancy. In the Cu group haemoglobin concentrations at 16 
weeks were estimated in II of the 16 women (69 %) and in the Cw group in 
15 of the 38 patients (40 %). In the first group the mean concentration was 
13.2 g/100 ml with only 4 readings below 13.0 g/100 ml (36 %) while in 
the second group the mean was 12.4 g/100 ml with II of the 15 readings 
below 13.0 g/100 ml (73 %). These figures would suggest that in normal 
women the main fall in haemoglobin concentration due to haemodilution 
occurs between the 16th and 20th weeks of pregnancy. The mean haemoglobin 
concentration at the post -natal visit was 13.9 g/100 ml. in this group so that 
there had been a slight fall in the mean value by 16 weeks. This may reflect 
individual variation among the women studied. The high proportion of women 
attending by 16 weeks in the Cu group is also noteworthy and may be an 
indication of greater prudence in matters concerning health. 
Perhaps the most important finding in this study of haemoglobin 
levels is that normal non - anaemic women show the same pattern and the 
same range of haemoglobin levels as women who are treated with iron alone 
or with iron + folic acid. There is no difference between the mean values 
in late pregnancy (36 weeks and later) or at the post -natal visit. Indeed 
slightly lower values are recorded in the group on iron + folic acid. 
Eighty per cent of women however show an increased haemoglobin 
concentration when given iron in pregnancy (Kerr,& :_Davidson, 1958) and one 
has to consider whether this is sufficient evidence that these women were 
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anaemic. Iron has a'pharmacological as well as a nutritional effect 
(Witts, 1963). This has been demonstrated by Paintin et al (1966). 
These workers compared the effect of low and high doses of iron in 
pregnancy. The low iron group received 12 mgms of iron daily in tablet 
form and it was anticipated that this would have shown some effect on 
haemoglobin concentration and red cell volume had the women been iron 
deficient. In practise this dosage had almost no effect. The high iron 
supplement (100 mgms per day) produced the type of response usually 
reported. When iron was given in therapeutic doses Paintin and his 
co workers noted a fairly uniform increase of red cell volume ( 160 ml). 
This suggested to them that iron, in large quantities, had a specific 
stimulating effect on erythropoiesis. The iron binding capacity remained 
high in this group indicating that in pregnancy an elevated total iron binding 
capacity is not an indication of iron deficiency. Stimulation of erythropoiesis 
with large doses of iron seems Ito occur only in pregnancy. Most workers 
report no effect when iron is given to normal men and normal non -pregnant 
women (DeLeeugv et al, 1964). Beutler et al, however, found a response 
in women with normal haemoglobin levels but with bone marrow depleted 
of iron stores. Iron stores are commonly reduced in pregnancy (Holly & 
Grund 1959) and this, together with the major physiological changes which 
occur to ensure transfer of iron to the foetus and enlargement of the 
haemoglobin mass, may make possible the erythropoietic effect of a large 
iron supplement. 
In the majority of the published series, in which iron in 
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therapeutic doses has? been given to pregnant women, a proportion show 
no increase in haemoglobin levels and some may show a fall. In the 
series of Paintin et al (1966) 4 of the 56 women in the high iron group 
showed no increase in haemoglobin concentration. Scott and Govan (1949) 
divided their cases into three groups 40% who improved, 52% who showed 
no change and 8% who deteriorated. This finding has been variously 
explained:- 
a) Failure to take the tablets agiven 
b) Failure to absorb iron 
c) An unusually large increase in plasma volume 
(Whiteside 1960). 
d) A mild folic acid deficiency 
The occurrence in some cases of mild and unsuspected folic 
acid deficiency in pregnancy has been accepted since the work of Chanarin 
et al (1959). Chisholm (1966) reported that in spite of the iron therapy 12% 
of Oxford women near term had haemoglobin concentrations of less than 
II g/100 ml. Overt megaloblastic anaemia due to folic acid deficiency 
was uncommon. The possibility that these women were reflecting a mild 
folic acid deficiency was investigated by comparing haemoglobin levels in 
late pregnancy between women on iron and women on iron + folic acid. 
There was no significant difference between these groups. Giles and 
Burton (1960) report a similar investigation in which a much larger group 
was 
of women studied and in which larger doses of folic acid were given 
(15 mgms /day as compared with 5 mgms /day). In their series the mean 
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- haemoglobin level at term in the group on Iron + Folic acid was 12.17 g/100 
which was significantly higher than the mean level of 11.81 g/100 ml found 
in the control group who only took iron. 
In the present investigation a rather smaller dose of folic acid 
(3.4 mgm /day) was given from an earlier stage in pregnancy. There was no 
significant improvement in haemoglobin levels in comparison with patients 
on iron only. Indeed at 28 weeks the mean haemoglobin concentration in the 
I +F group was 0.2 g/100 ml lower than in the group on iron and this was 
significant at the 5% level. The range was very similar in both groups. 
It seems probable that the socio- economic conditions under which 
these women lived were more comparable with those of women in the Oxford 
area (Chisholm, 1966) than in Stoke on Trent (Giles & Burton, 1960). Inadequate 
diet is an important aetiological factor in the development of megaloblastic 
anaemia of pregnancy and folic acid deficiency (Lowenstein et al, 1966; Giles 
& Burton, 1960). It is therefore not surprising that Giles and Burton should 
report improvement in haemoglobin levels when additional folic acid was given 
to a population in which inadequate diets are common; or the failure :to 
demonstrate this phenomenon in more fortunate areas. 
Haematocrit Levels 
In non - anaemic pregnant women the haematocrit levels parallel the 
levels of haemoglobin concentration. The completely untreated group in this 
investigation show similar mean values to those found in treated groups. The 
lowest mean value is 36% which is only slightly lower than the lowest mean 
of 36. 7% reported by Rath et al (1950). Hytten and Duncan (1956) quote 34% 
as the average lowest haematocrit reading in normal pregnancy. Hytten and 
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Leitch (1964) comment on the similarity of the findings of Rath et al 
(1950) to those reported when iron had been given (Lund 1951). They 
suggest that the women may have been taking iron supplements of their 
own accord. Women in the Cu group in this series were carefully questioned 
on this point and were not taking iron. It would seem therefore, that a 
proportion of women are able to maintain a haematological balance in 
pregnancy with haemoglobin and haematocrit levels of the same order as 
those found in treated women. This will be discussed further under iron 
metabolism. 
The mean haematocrit levels in the Cw group were slightly lower 
than the mean values in the other groups. It is however, of interest to 
note that at 28 and 36 weeks the values at the lower end of the range are 
higher than in the other groups. This was not observed with haemoglobin 
levels and is no doubt due to the increasing hypochromia in these patients. 
Mean Corpuscular haemoglobin concentration 
The mean cell haemoglobin concentration varies very little in 
normal pregnancy or when iron is given (Lund, 1951; Hytten & Duncan, 1956). 
There is, however, a definite decrease in iron deficiency anaemia. Vogel et 
al (1963) found the MCHC a vaCutable means for assessment of the degree of 
anaemia and also the response to treatment. Paintin & Hytten considered 
a fall in MCHC to be a rather late sign of iron deficiency. In the present work 
the mean value in the Cw group is low only in comparison with the mean 
values of the other groups but the difference at 36 weeks is significant. In 
addition at 36 weeks individual readings fall in a lower range. 
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Iron Metabolism 
Iron balance in any individual depends on the needs of the body, 
the amount available in the diet, the efficiency of absorption and the daily 
loss in urine, faeces, sweat, desquamation of epithelial surfaces and, in 
women, menstruation. In men and non - pregnant women it is only necessary 
to replace iron lost from the body. Garby (1966) estimates this as 0.4 mgm /day 
in men and 1.0-2.0 mgm /day in women. He does not, however, include loss 
by desquamation in his calculation. 
In pregnancy there is the additional burden of supplying iron to the 
foetus and placenta as well as to the increased red cell mass made necessary 
by the increased vascular bed. There are various estimates in the literature 
of the amount of iron needed by the pregnant woman. Scott (1962) quotes a 
final deficit of 680 mg if the woman breast feeds and 500 mg if she does not. 
Paintin et al (1966) calculate that by the end of pregnancy a total of 867 mg 
will be required. They do not estimate the amount of iron which. will return 
to stores when the red cell mass returns to normal after delivery. Bothwell 
& Finch (1962) quote a total need, in pregnancy, of 550 mgm of iron in 
comparison with a requirement of 336 mg in a non -pregnant woman during the 
same period. 
The need for iron varies throughout pregnancy. Bothwell and Finch 
(1962) consider that requirements in the first trimester are covered by the 
saving of iron due to amenorrhoea. The daily need in the first trimester given 
by Paintin et al (1966) is 2.1 mg. which is of the same order as the upper limit 
of iron required by a non -pregnant woman (Garby 1966). In the second trimester 
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a daily absorption of 3. 9 mg. is needed and in the third trimester 4.2 mg. 
(Paintin et al 1966). These figures are very similar to those quoted by 
Bothwell and Finch (1962) when it is remembered that they do not allow for 
loss due to desquamation in their calculations. A survey in 1954 showed that 
the average diet in the United Kingdom contained 13 mg. of iron per day 
(Ministry of Agriculture, Fisheries and Food, 1956). It seems improbable 
that this has altered to any extent in recent years. The amount available 
for utilisation by the pregnant woman will depend on individual rates of 
absorption. 
The most extensive work on the rate of iron absorption in 
pregnancy seems to be that of Hahn et al (1951). Using a dosage of 18 mg. 
of iron they demonstrated a median uptake of 10% in early pregnancy ( <15 weeks) 
and this increased to 26% in the last four weeks of pregnancy. When therapeutic 
doses were given these figures fell to 2. 2% and 8% respectively so that for a 
6 -7 fold increase in dose there was only a 2 fold increase in absorption. 
The authors comment on a wide individual variation in their results so these 
were expressed as "Median % Uptake" when "Uptake" = Factor of 
absorption + Utilisation. Prtichard and Adams (1960) also found evidence 
of increased red cell utilisation cf iron. In their series, by the 7th day 
after injection, pregnant women showed 91% utilisation of the injected isotope 
in red cells as compared with a 76% utilisation in non -pregnant women. 
been 
Various factors have shown to influence absorption. Pirzio -Biroli 
& Finch (1960) found that the extent of the iron stores had a considerable 
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influence on the rate of absorption. A normal mean absorption of 6% was 
reduced to 3% when iron stores were increased to 1. 5 g. Conversely 
absorption increased to 20% following sufficient reduction of iron stores. 
Iron stores can most conveniently be estimated by examination 
of bone marrow. Conrad et al (1962) found that when young men were bled 
serially bone marrow was the last iron reserve to be depleted. and the last 
to recover. 
Absence of marrow iron has been repeatedly observed in a high 
proportion of p3egnant women (Holly & Grund, 1959; Allaire & Campagna, 
1961). This finding has usually been related to iron deficiency but it seems 
possible that iron requirements in early pregnancy are to a large extent 
provided from marrow stores and reduction of these stores would then 
stimulate increased absorption. The work of Hahn and his colleagues provides 
some support for this possibility as they found a significantly higher uptake 
of iron in early pregnancy in the higher parity groups. Iron stores are likely 
to be reduced at the beginning of pregnancy in multiparous women (Scott 1961). 
Iron is present in small quantities in the .blood serum as well 
as in haemoglobin and in the body stores. Abderhalden in 1898 was the first 
to recognise the presence of iron in the blood which was not bound up in the 
haemoglobin molecule. Häuserman (1899) showed that this non -haemoglobin 
iron was present in the plasma. The work was extended and confirmed by later 
workers (Fontes & Thivolle, 1925; Warburg & Krebs 1927) and today this 
fraction is known as 'serum iron' (Dahl, 1948). More recently it has been 
demonstra ted that iron is carried in serum bound to the protein fraction now 
identified as /f - globulin (Surgenor et al 1949; Cartright & Wintrobe, 1949). 
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This is not a single entity, as several distinct bands can be distinguished) 
but as the ability to transport iron seems uniform,the complex is usually 
considered as such (Bothwell & Finch, 1962). The iron combining 
globulin is called transferrin and a proportion is always unsaturated. 
The level of unsaturated transferrin varies in relation to iron metabolism 
(Ventura & Klopper, 1951). 
The relationship of bound iron in the serum (serum iron) tototal . 
iron binding capacity (serum iron + unsaturated transferrin) can be expressed 
as % saturation of transferrin. Taylor & Gatenby (1966.).:.:found a significant 
relationship between this figure and the rate of iron absorption. There 
was also a significant inverse correlation with serum iron levels. Serum 
iron levels fall in normal pregnancy when no treatment is given (Ventura 
& Klopper 1951; Holly, 1953). Rath et al(1950) are the only observers who 
report a maintenance of se rum iron levels in late pregnancy and it has already 
been suggested that their patients may have taken iron (Hytten & Duncan 1956). 
A fall in serumiron levels will automatically cause a fall in % 
saturation of transferrin and this is further exaggerated by the increase in 
transferrin levels which occurs in pregnancy. Raised transferrin levels are 
also found in the presence of iron deficiency anaemia and the occurrence of 
this change in pregnancy has been put forward as an indication of iron deficiency, 
but raised levels persist even when iron is given, - 
Increased transferrin levels in pregnancy in the absence of iron 
deficiency may be explained by the work of Weinfeld (1965). This worker found 
that a rise in storage iron was associated with a fall in total iron binding 
capacity. It seems reasonable to deduce that utilisation of storage iron in 
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pregnancy could be associated with an increased iron binding capacity. 
The fall in serum iron levels may have a hormonal basis. 
Palmer (1952) found that non -menstruating women of menstrual age have 
the same lower serum iron levels that are found in menstruating women. 
A similar observation was made in rabbits who do not menstruate. In 
addition when oestrogens were given to both male and female rabbits 
there was a fall in serum iron. Fujino et al (1966) found an inverse 
correlation between serum iron and oestrogen levels but Zilva'and Patston 
(1966) reported some correlation between low serum iron levels and the lowest 
levels of urinary oestrogen in normal menstrual cycles. 
Active erythropoeisis also increases absorption of iron (Weintraub 
et al, 1965), and can indeed continue to promote iron absorption in the presence 
of high iron stores (Sephton Smith, 1965). It is a matter of general experience 
that marrow hyperplasia occurs in pregnancy (Callender 1946). Holly & Grund 
(1959) however, found evidence of depressed erythropoeisis in pregnancy. 
This was a very unexpected finding and the work was repeated by Pritchard 
and Adams (1960) and they found that erythropoeisis was actually accelerated. 
It would therefore seem that in pregnancy there are physiological 
changes which promote increased absorption and utilisation of iron. In a normal 
woman with adequate iron stores and a sufficient diet it is unnecessary to give 
additional iron. Indeed, by artificially raising the serum iron one would seem 
to risk interference with the normal mechanism of the body. 
It also has to be remembered that at the end of pregnancy the red 
cell volume is reduced to normal. Some blood is lost at delivery and in the 
placenta but there is still an appreciable volume of red cells to be broken down 
-43- 
and the iron content will then be returned to storage. This 'pay- back" 
of iron has been variously estimated. Rath et al (1950) give a figure of at 
least 500 mg. Bothwell & Finch (1962) 100 -140 mg. and Beaton (1966) 230 mg. 
If therefore, it is possible for a pregnant woman to continue to absorb iron 
in excess of her needs, large doses of mineral iron during pregnancy could 
lead to iron over load in the puerperium. This has been shown to occur in 
the Bantu women described by Gerritson & Walker (1954) as half of these 
women had haemochromatosis at autopsy (Hytten &Duncan, 1956). These 
women are, however, a special group and in general large deposits of 
haemosiderin are rare in women (Finch & Finch, 1955). 
The present work is illustrated by scattergrams depicting the 
individual readings of serum iron, total iron binding capacity, latent 
(or unsaturated) iron binding capacity and % saturation. In these figures 
the mean values at the weeks studied are joined by a solid line (Figures 
2 -5). In addition an attempt has been made ro illustrate the different patterns 
of iron metabolism in treated and untreated women. In these figures 
(Figures 6 & 7) the 20 week levels are taken as 100% and later readings are; 
plotted as percentage increase or decrease on these values. Serum iron, 
total iron binding capacity, latent iron binding capacity and % saturation are 
plotted on one graph for each group studied. It is not suggested that these 
graphs express more than a general pattern of the behaviour of the variables 
as there is not complete uniformity between the 20 week levels in the different 
groups. This particularly applies to the Cu and Cw groups as these are 
sub - divisions of the original untreated group. 
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Mean serum iron levels rise during pregnancy in the treated 
groups. This has also been the experience of many previous workers 
(Sturgeon, 1959; Holly & Grund, 1959). The mean values and range'.are 
also similar. The experience of Verloop et al (1959) differed in that their 
patients treated with iron showed a slight fall in mean serum iron levels 
in late pregnancy. Malkosian et al (1964) after an initial rise on iron record 
a slight fall at 40 weeks. A wide range of individual readings seem to be a 
general finding and may explain lack of uniformity in mean values. 
The untreated groups show the expected fall in serum iron levels. 
The pattern of the fall is not so steep in the Cw group but the 20 week level 
was significantly lower than in the other groups. The Cu groupshows a 
maximum fall at 36 weeks when it is 27% below the 20 week level. This 
fall is of the same order as has been previously reported (Ventura & Klopper, 
1951; Lund, 1951). At 40 weeks there is an unexpected rise in the mean value 
which is accompanied by a fall in unsaturated iron binding capacity; the total 
iron binding capacity continues to rise at this time. It therefore seems 
unlikely that this finding is associated with the fall in plasma volume which 
usually occurs in late pregnancy. The observation is difficult to explain but 
as only five readings are available at 40 weeks it would probably be unwise to 
attempt any interpretation of the finding until further studies are made. 
The mean values for total iron binding capacity (TIBC) and latent 
iron binding capacity (LIBC) are rather lower in this investigation than have 
been previously reported. This may be related to the variety of methods used 
by different observers. Total iron binding capacity was the only variable in 
this study which was not comparable in the three main groups of the original 
Fig. 6. Patterns of Iron Metabolism 
Patients on Iron Patients on Iron + Folic Acid 
36 40 P.N.weeks 
.--.Serum Iron 
- T.I.B.C. 
- - - L.I.B.C. 
- - -o % Saturation 
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protocol at 20 weeks. This seemed to be due to six wild readings in groups 
1 and 2 (Vol. 2, p. 44 -45). This view is supported by the almost identical 
mean value for TIBC which is seen in the group on iron at 28 weeks and 
the associated fall in the mean value of LIBC. With this exception TIBC and 
LIBC rise very similarly in the I, I +F and Cu groups until 36 weeks. Group 
Cw, however, shows a significant increase in the mean values of both TIBC 
and LIBC at 36 weeks. The group on iron demonstrates a fall in both of these 
variables at 40 weeks. Malkosian and his co- workers also record this 
behaviour in their cases treated with iron. The group on iron + folic acid 
behaved differently. In this group the total iron binding capacity and latent 
iron binding capacity continue to rise at 40 weeks. The behaviour of % saturatior 
is also interesting. The untreated groups show the expected steep fall during 
pregnancy although there is a slight rise in the mean value in the Cu group at 
40 weeks. In the treated groups an initial rise occurs in both and the level 
reached is maintained throughout pregnancy, with reasonable uniformity, in the 
group on iron. In comparison the mean value in the I +F group shows a fall at 
36 and 40 weeks. s It is suggested that this is areflection of the relatively 
greater increase of the transferrin pool in women who receive folic acid in 
addition to iron. 
The different modes of behaviour are shown more clearly in the 
graphs which are constructed by using % variation on 20 week levels for the 
four variables studied in each group. The increase of the transferrin pool is 
relatively greater in the untreated groups as judged by the patterns for total 
and latent iron binding capacity. Ventura & Klopper (1951) attributed this to 
Fig. 7. Patterns of Iron Metabolism 
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"the vastly increased turnover of iron in late pregnancy" but Hytten & 
Duncan (1956) thought it c ould be explained by the rise in concentration of 
plasma globulin. In the Cw group it seems likely that it also reflects some 
degree of iron deficiency. The treated groups also show an increased 
transferrin pool and this is relatively greater in the group on iron and folic 
acid. Lane (1966) found a close association between % saturation and total 
iron binding capacity. He also comments on the possibility that iron has some 
effect on liver activity in the synthesis of transferrin. It is generally accepted 
that folic acid plays an important part as folate co- enzyme in normal 
erythropoeisis and nuclear synthesis (Luhby & Cooperman, 1964) but otherwise 
little is known of its function in ".body metabolism. The present findings would 
seem to indicate increased activity of the transferrin pool when folic acid is 
given in addition to iron. It seems possible that folic acid may have some 
function in iron metabolism which is demonstrated when additional folic acid 
is given as well as additional iron. It is also suggested that therapeutic doses 
of mineral iron in normal pregnant women cause an imbalance of the metabolic 
process. The addition of folic acid would restore this balance and metabolic 
behaviour would then approximate more closely to that found in normal 
untreated women. Indeed, allowing for the differences due to increased 
serum iron the pattern of behaviour in the Cu group shows more similar ity 
to the I +F group than to the group on iron only. 
These observations, of course, are not intended to apply to women 
who are frankly deficient in either substance. 
Fig. 8. Serum B12 Levels; Scattergrams and Mean 
Values 
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Observations: II. Serum B12 and Serum folate 
Serum B12. (Vol. 2, p. 65 and Figure 8). 
Weeks I 
Mean Values and Range (}zpzg /ml) 
(Number of estimations in brackets) 
I + F Cu Cw 
20 268 (27) 273 (27) 254 (8) 239 (21) 
140 -598 115 -479 128 -409 152 -459 
28 252 (28) 222 (27) 227 (8) 227 (11) 
130 -528 57 -412 120 -397 104 -444 
36 212 (29) 204 (24) 224 (8) 195 (4) 
105-504 73-320 145-379 159-246 
40 202 (12) 208 (20) - (1) 
108-341 83-341 
PN 375 (29) 348 (26) 337 (8) 
189-835 153-556 228-520 
There were no significant differences between any of the mean 
values at the weeks tudied. Following the commencement of treatment 152 
results were available for inspection in the group on Iron, 150 in the group 
on Iron and Folic Acid, 41 in the completely untreated group and 44 in the 
group which would require treatment. The number of readings of less 
than 100 ppgms /ml were counted in these groups with the following results. 










It was also observed bn inspection that although the mean values 
Fig. 9. Serum Folate; Scattergrams and 
Mean Values 
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at the end of pregnancy were very similar in both of the treated groups 
the initial rate of fall seemed to be much greater in the group on Iron + 
Folic acid. The proper correction for serial correlation was applied and 
mean values for the rate of fall in the treated groups were calculated for the 
periods, 20 -28 weeks, 20 -36 weeks and 20 -40 weeks. When these were 
compared it was found that the rate of fall in the I + F group in the 20 - 28 
week period was greater than the rate of fall in the group on Iron (p <0.05). 
No significant differences were found between the groups for the other periods 
tested. 
Serum folate. (Vol. 2, p. 72 and Figures 9 & 10) 
Mean Values and Range (mp.g /ml. 
(Number of estimations in brackets) 
Weeks I I +F Cu Cw 
20 5. 5 (26) 5. 3 (17) 4. 7.(7) 5. 1 (21) 
1.7-20.5 2.0-12.5 2.7-7.3 1.5-14.5 
28 4.9 (26) 54.3 (26) 4. 9 (8) 5.6 (10) 
2.3-13.0 18.3-70.0 2.6-6.6 2.3-11.2 
36 4.3 (28) 51.7 (26) 5.4 (8) 4.2 (4) 
2.0 -6.6 9. 0-. 70.0 4.3 -10.3 3.0 -5.5 
40 3. 8 (15) 54.2 (20) - (2) 
2.8 -6.9 6.7 -70.0 
PN 4. 8 (29) 14. 0 (26) 5. 2 (8) 
1.8-10.3 5.3-34.0 2.8-7.3 
* One result of 38 mpg/ml was excluded in calculating the mean. ; 
There were no significant differences between the mean values at 
20 weeks. At the remaining weeks tested as would be expected, the mean serum 
folate levels in the I +F group were significantly higher than in the other groups:- 
Fig. 10. Serum Folate; Scattergrams and Mean Values 
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28 weeks I +F vs I : p < 0. 0005 
I +F vs Cu: p < 0. 0005. 
I +F vs Cw: p <' 0. 0005 
36 weeks I +F vs I : p < 0. 0005 
I +F vs Cu: p ( 0. 0005 
I +F vs Cw: p < 0. 0005 
40 weeks I +F vs I : p ( 0. 0005 
PN - I +F vs I : p < 0. 0005 
I +F vs Cu: p < 0. 0005 
In addition at 36 weeks the completely untreated group had a 
significantly higher mean folate level than the group on Iron (p(0. 025). 
The mean regression co- efficient was negative in the group 
on iron and this was significant using Fisher's test (p(0. 05). The I +F 
group showed a p6sitive linear regression and the mean regression 
co- efficient was significantly greater than in the other two groups (p <0. 005). 
The wide range of readings in the I +F group is probably due to 
to the relationshipbetween the time of day at which spec.imens were taken 
and the time of taking tablets. Cases where relatively low figures were 
recorded during pregnancy had high readings at the post -natal visit so 
that failure to take tablets was not suspected. 
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(Number of estimations in brackets) 
I I + F Cu 
3.34 (48) 3.33(26) 3. 24 (16) 
2.97 -3.78 3.00 -3.60 3.04 -3.54 
3.27 (46) 3. 29 (51) 3.29 (16) 
2. 91-3. 58 2. 96-3. 63 2. 99-3. 53 3. 03-3. 56 
36 3. 27 (47) 3. 24 (49) 3. 27 (16) 3.22 (9) 
2.98 -3.57 2.96 -3.66 2.98 -3.59 2.95 -3.39 
40 3. 27 (27) 3. 24 (32) 3. 18 (6) 
3. 03-3. 56 2. 86-3. 55 2. 86- 3. 30 
PN 3.36 (48) 3.34 (51) 3.34 (16) 
3. 04-3. 65 2. 87-3. 60 3. 06-3. 57 
The only significant differences between mean values were 
found at 20 weeks: 
Cu vs I : 1340. 05 
Cu vs I+F: p <O. 01 
The mean regression co- efficient was positive in the completely 
untreated group and negative in both of the treated groups. These 
differences were significant : - 
Cu vs I : p< O. 05 
Cu vs I+F: p <0. 01 
There was also a significant correlation between Serum Folate 
level and Mean lobe Count in the group on iron + folic acid (r = -0. 295, 
p <0. 01). This correlation was not demonstrated in the other groups. 
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Discussion 
Pernicious anaemia of pregnancy was recognised before the 
publication of Biermer's reports of 1868 and 1871. Many of Biermer's 
cases were associated with pregnancy and for some years there seems 
to have been some confusion in distinguishing between pernicious anaemia 
of pregnancy and primary pernicious anaemia, (Pepper, 1927). The 
situation was clarified by Osler (1919) when, in describing the severe 
anaemias of pregnancy and the post - partum period, he pointed out that 
"although progressive and often pernicious, the anaemia is caused by an 
agent which differs irí one all important particular from that which causes 
the anaemia of Addison. When recovery takes place it is permanent, and 
the woman may escape in subsequent pregnancies ". 
The next important advance followed the work of Wills in 
India. She described severe macrocytic anaemia of pregnancy which 
responded to treatment with liver or marmite (Wills & Mehta, 1930). 
Similar anaemias in non - pregnant women and men were described, 
particularly in tropical countries (Moore et al, 1944). It is not always 
clear whether these are megaloblastic anaemias as the marrow biopsy 
rate was low. In 1945 Spies et al demonstrated that patients with 
pernicious anaemia and nutritional macrocytic anaemias responded to 
folic acid which was a member of the vitamin B complex. Megaloblastic 
anaemia of pregnancy also responded to folic acid (Moore et al, 1945). 
It was soon found that this substance was not the active anti -pernicious 
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anaemia factor of liver as there was no improvement in the neurological 
conditions associated with pernicious anaemia (Heinle & Welch 1947), 
and often the y progressed more rapidly (Ross et al, 1948). At about 
the same time Vitamin B was isolated and was soon shown to be 
12 
identical with Castle's extrinsic factor (Berk et al, 1948). 
In addition to iron there were nomtwo further substances which 
had been shown to be necessary for normal erythropoeisis. Vitamin 
B12 was specific for the treatment of primary pernicidus anaemia but, 
at least in temperate zones, megaloblastic anaemia of pregnancy, dietary 
deficiency and malabsorption responded to folic acid. 
Folic acid deficiency anaemia of pregnancy has been reported 
with increasing frequency in recent years. Stevenson (1938) reported 
30 cases in a 6 year survey, Thompson & Ungley (1951) found 46 cases 
in 17 years but at this time, Lund (1951) estima ted that 1% of all pregnancy 
anaemias in the New Orleans area were of this type. Since then the 
incidence reported in the United Kingdom has risen markedly. Giles & 
Shuttleworth (1958) roused considerable interest in the condition when they 
reported an incidence of 2. 8% in Stoke on Trent. By 1965 Hibbard et al 
described megaloblastic changes in the marrow in 4. 2% of a group of 167 
unselected women attending an ante -natal clinic in Liverpool. They 
concluded that not less than 10% of women in their area had folate 
deficiency during pregnancy and that in nearly half of the cases it was 
sufficiently severe to cause megaloblastic erythropoeisis. 
The concept of folic acid deficiency without megaloblastosis of 
the marrow is of fairly recent origin. It has arisen with the recognition 
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of earlier changes in red and white cells and their precursors e. g. 
macro -ovalocytes, atypical normoblasts, transitional cells, giant 
metamyelocytes and hypersegmented neutrophils. Some workers also 
find excretion of formimino - glutamic acid (FIGLU) in the urine after 
histidine loading a useful test of folate deficiency (Hibbard et al 1965; 
Scott & Sommerville, 1965). Chanarin et al (1963), Chisolm & Sharp 
(1964) and Chanarin (1964) did not find this a dependable test in 
pregnancy because of alterations in histidine metabolism. 
The classical paper on the pathogenesis of megaloblastic 
anaemia in pregnancy was published in 1959 by Chanarin, O'Sullivan, 
MacGibbon and Mollin. These workers studied the clearance of folic 
acid from the plasma after intra- venous injection of a small dose. The 
rate of clearance was found to be increased in two- thirds of women in 
late pregnancy and in all women with twin pregnancies. Clearance 
rates were even higher in women with megaloblastic anaemia of pregnancy. 
It was concluded that folic acid deficiency was due to foetal requirements 
exceeding the dietary intake with the additional possibility that impaired 
absorption might also play a part. 
Lowenstein et al (1962) found good correlation between megalo- 
blastic anaemia in pregnancy and serum folate activity when L. casei was 
used. ; They considered that in pregnancy values of 3. 1 - 4. 0 mpg/m1 
indicated borderline deficiency. Solomons et al (1962), however, reported 
a mean value of 4. 3 mpg/ml in normal pregnancy as compared with a mean 
value of 7. 8 mfg /ml in,the non - pregnant. 
Herbert (1964) discussed the value of the presence of hypersegment 
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ed neutrophils (PMN) as a means of early diagnosis. He recommended 
making a mean lobe count per 100 PMN as a simple1:way of expressing 
the result. In his laboratory the normal mean lobe count was 3.17 
(-0.25) but the figure is liable to vary from one laboratory to another. 
For this reason Chanarin et al (1965) preferred to note the percentage 
of cells with 5 or more lobes. They gave 3% as the upper limit of 
normal. 
In 1965 Chanarin and his colleagues published a comprehensive 
study of folic acid status in pregnancy. The construction of the project 
was similar to that described in the present work. Groups of women on 
iron, iron + 30 pg. folic acid or on a placebo were followed-through 
pregnancy and the whole question of folic acid status in pregnancy was 
discussed. They reached the conclusion that the diagnosis of megalo- 
blastic anaemia in pregnancy and in the non - pregnant was still dependent 
on marrow morphology. Serum folate & Figlu estimations were not 
uniformly reliable. They found that even transient presence of hyper - 
segmented neutrophils was a valuable indication that examination of the 
marrow was advisable. Megaloblastosis could, however, be present . 
with no other indications of abnormality. Among the 15 cases with 
megaloblastic erythropoeisis 4 were found in women who had marrow 
biopsies done in order to obtain controls. They confirmed the observation 
of Solomons et al that serum folate levels fall during pregnancy and 
concluded that this indicated a high incidence of sub - clinical folic acid 
deficiency. They also found that serum folate levels were lower in the 
presence of iron deficiency and considered this condition to be an 
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important aetiological factor in the development of folic acid deficiency. 
This view was supported by Varadi (1965) and also by tie work of Vitale et al 
(1966) on rats. These workers induced morphological changes of folate 
deficiency in rats kept on an iron deficient diet even when adequate folic 
acid was supplied. They concluded that this effect was related to the 
decreased activity of the enzyme formimino -transferase which depends 
on iron for optimal activity. Giles & Ball (1965) disagreed with this 
finding. They pointed out that it was a matter of clinical experience 
that folic acid deficiency could be precipitated when large doses of iron 
are given. These observations are not incompatible, as the behaviour 
of individual cases will depend on the relative sufficiency or deficiency 
of iron and folic acid. 
Many workers now advise the routine administration of folic 
acid in pregnancy (Lowenstein et al, 1962; Giles, 1966); at least in 
industrial areas or where dietary deficiencies are common. There was 
some concern at first that routine treatment with folic acid'tould 
precipitate neurological .complications in women with undetected 
pernicious anaemia. Witts (1962) pointed out that although pernicious 
anaemia can occur in the childbearing period it is usually associated 
with sterility so that pregnancy is very unlikely to occur. Although 
serum B12 levels fall in normal pregnancy (Ball & Giles, 1964; Metz 
et al, 1965) it seems unlikely, even if there is a greater fall when 
i 
additional folic acid is given, that this would a sufficient to precipitate 
pernicious anaemia as body stores of vitamin B have been shown to 
i 
last 4 or.5 years after total gastrectomy. This problem would seem to have 
Figure 12. Pattern of Serum B Changes 
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Note: The graph for the Cu group is broken at 40 weeks 
because of insufficient results. 
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been solved by the recent work of Willoughby & Jewell (1966) who 
found that when 300 ?,'jig of folic acid were given daily in pregnancy 
serum folate levels comparable with those found in normal adults 
were maintained. This is fortunate as Herbert (1966) has shown that 
daily doses of 400 Jug of folic acid may produce a response in 
some cases of megaloblastic anaemia due to vitamin B12 deficiency. 
The results of the present work are illustrated by Figures 8, 
9, 10, and 11 which show individual readings for serum B12, serum 
folate and mean lobe counts presented as scattergrams with a line 
joining the mean values. In addition the patterns of behaviour of these 
three variables are again illustrated diagramatically by expressing the 
readings as the percentage variation an the 20 week level which is taken 
as 100% (Fig. 12, 13, & 14). 
A comparison of serum B12 and folate levels in the four groups 
of women in this investigation would seem to show a relationship between 
the metabolism of iron, folic acid and Vitamin B12. The completely 
untreated group as has already been said are haematologically well 
adjusted. In this group no imbalance is produced by givening additional 
haematinics. Mean serum B12 levels fall in the Cu group at least to 
36 weeks (unfortunately there was only one reading at 40 weeks). 
The fall in serum B 12 in pregnancy is generally reported and also the 
rapid return to normal le vels which occur after delivery. Metz et al 
(1965) suggest that the fall represents a change in metabolism due to 
pregnancy and that the rapid rise after delivery expresses the removal 
of whatever factor has caused the depression. There is no rise in 
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late pregnancy so there would not seem to be any association with 
volume changes. The fall by 36 weeks is greater in the treated groups, 
both when the mean values are studied and also when the percentage fall 
on the 20 week level is considered. It is of interest that the Cu group 
and the group on iron + folic acid show the greatest rate of fall between 
20 and 28 weeks. The rate of fall then flattens so that similar levels 
are reached by the group on iron and the I +F group at 36 and 40 weeks. 
It is suggested that normal behaviour is represented by the Cu group 
while the treated groups respectively reflect lackof folic acid and 
vitamin B12 or of vitamin B12. It would be of interest to make a similar 
study when additional vitamin B12 is also given. Metz and his colleagues 
report a similar pattern when 50 pg vitamin B12 were given daily but they 
mention a transient rise of mean values in the 8 week period after starting 
the supplements. 
The serumfolate levels are of particular interest. There was 
no fall in the mean folate levels in the Cu group, This would seem to be a 
contradiction of the findings of Chanarin et al (1965) but this is not 
necessarily so. The untreated group of these workers was comparable 
with the Cu and Cw groups of the present investigation and there is a 
relatively rapid fall of the mean serumfolate value in the Cw group at 
36 weeks. In the same way the serum B12 levels show the lowest mean 
value recorded in the investigation at 36 weeks in this group. The range of 
both variables is also lower. In contrast to the normal untreated group 
women on iron show a gradual fall in mean serum folate levels throughout. 
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pregnancy with a return to a normal mean value at the post -natal visit. 
It is again suggested that this reflects an imbalance of iron and folic acid. 
The mean lobe count in the Cu group was significantly lower 
than the mean lobe counts in the tre ated groups at 20 weeks so that 
comparison of the changes is approximate. The general pattern in 
normal pregnancy would seem to be that there is no alteration from the 
non -pregnant state. A fall is noted at 40 weeks but only 4 values are 
represented. 
Both of the treated groups show a fall in the mean lobe count 
throughout pregnancy with a return to the 20 week level at the post -natal 
visit; by which time no supplements had been given for 6 -8 weeks. The 
fall in mean lobe count in the group on iron is of interest in view of the 
finding of Chanarin and others that hypersegmenl d neutrophils can be 
associated with iron deficiency anaemia as well as with megaloblastic 
anaemia (Chanarin et al, 1965). This point is also illustrated by the 
case of Mrs. J. M. in the present series (Vol. 2, p. 165). 
Hypersegmented neutrophils were rarely seen,. but it is of 
interest to note that at the post -natal visit 3 of the 46 women on iron had 
blood films with 3% hypersegmented neutrophils (5 +lobes) while in the 
I +F group only one of the 50 women examined reached this figure. 
Fig. 15. Blood volume; Scattergrams and Mean Values 
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Chapter 5 
Observations: III. Volume Changes. 
Blood Volume . (Vol. 2, p. 85 and Figure 15). 
Weeks I 
Mean Values and Range (ml) 
Cw 
(Number of estimations in brackets) 
I + F Cu 
20 5489 (20) 5640 (23) 5160 (8) 5406 (17) 
3500 -9400 3240 -9150 3695 -6770 3620 -9200 
28 5760 (19) 5408 (24) 6360 (7) 5442 (14) 
3120 -10300 3160 -7960 3620 -11100 3600 -8940 
36 5780 (18) 4140 (22) 5270 (8) 6268 (5) 
3530 -9050 3120 -7710 3200 -7460 5040 -8100 
40 5200 (12) 4310 (11) 4190 (3) 
3690 -8310 3030 -5270 2930 -5010 
PN 3624 (20) 3660 (24) 3367 (8) 
2590 -5640 2770 -5290 2200 -5750 
There were no significant differences between any of the 
groups at any of the weeks tested. 
Plasma Volume. (Vol. 2, p. 90 and Fig. 16) 
Mean Values and Range. (ml) 
(Number of estimations in brackets) . 
Weeks I I +F Cu Cw 
20 3757 (20) 3856 (23) 3520 (8) 3728 (17) 
2420 -6600 2240 -6570 2595 -4570 2470 -6250 
28 3931 (19) 3685 (24) 4381 (7) 3763 (14) 
2220-7500 2160-5650 2410 -7690 2460 -6190 
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Weeks I I +F Cu Cw 
36 3857 (18) 3477 (22) 3610 (8) 4340 (5) 
2160 -6500 1940 -5260 2155 -5300 3480 -5600 
40 3439 (12) 2843 (11) 2776 (3) 
2330 -5240 1910 -3420 1900 -3420 
PN 2355 (20) 2377 (24) 2218 (8) 
1700-3710 1770-3560 1465-3920 
There were no significant differences between any of the 
groups at any of the weeks tested. 
The mean regression co- efficient was negative in the groups 
studied and there was no significant difference between them. When 
Fisher's test was 'applied to the regression co- efficients there was a 
significant result in the group on iron + folic acid ( p =<0.05). This was 
not found in the other two groups. 
Red cell Volume (Vo. 2, p. 95 and Figure 17). 
Weeks 
Mean Values and Range (ml) 
Cw 
(Number of estimations in brackets) 
I I +F Cu 
20 1732 (20) 1785 (23) 1646 (8) 1678 (17) 
1080 -2900 1000 -2580 1100 -2200 1080 -2950 
28 1829 (19) 1720 (24) 1984 (7) 1681 (14) 
900 -2940 1000 -2310 1210 -3410 1140 -2750 
36 1925 (18) 1695 (22) 1659 (8) 1928 (5) 
1190 -3070 1120 -2580 1045 -2170 1560 -2500 
40 1765 (12) 1466 (11) 1420 (3) 
1220 -3070 1120 -1950 1030 -1640 
PN 1269 (20) 1285 (24) 1149 (8) 
850-1930 910-1730 735-1830 
Fig. 17. Red Cell Volume; Scattergrams and 
Mean Values 
ml 
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There were no significant differences between any of the groups 
at any of the weeks tested. 
The mean regression co- efficient was negative in the three 
groups tested and there was no significant difference between them. No 
significant result was found in any group when Fisher's test was applied. 









Mean Values and Range. (G) 
(Number of estimations in brackets) 
I +F Cu Cw 
699 (23) 629 (8) 661 (17) 
398 -999 453 -855 445 -1204 
671 (24) 774 (7) 644 (14) 
476 -925 471 -1290 436 -1080 
36 750 (18) 663 (22) 661 (8) 730 (5) 
449-1180 431-964 413 -904 625 -916 
40 702 (12) 578 (11) 553 (3) 
480 -1230 440 -780 405 -633 
PN 509 (20) 505 (24) 456 (8) 
344-812 354-694 292 -725 
There were no significant differences between any of the groups 
at any of the weeks tested. 
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Mean Values and Range ( %) 
Cu (4) 
(Number of estimations in brackets) 
I (16) I+F (18) 
20 3. 45 3. 29 3.50 
1. 92-4. 34 2.42-4.61 2.92-4.20 
36 4.21 4.21 4. 06 
2.66 -5.46 2.67 -5.85 3.48 -4. 56 
PN 2. 54 2. 02 2. 05 
0. 96-3. 48 1. 17 -2. 86' 1. 15 -2. 92 
p<aGlobulin Fraction 
Weeks 
Mean Values and Range ( %) 
Cu (4) 
(Number of estimations in brackets) 
I (16) I+F (18) 
20 8. 91 8. 77 8. 68 
4. 56 -10.40 5. 60 -10. 98 6. 62 -10. 50 
36 9. 23 10.15 9. 02 
6. 25 -11.20 6. 54 -15. 26 7. 50 -11. 04 
PN 7.41 7. 6.49' 
4.40 -10.50 5. 67-9. 73 5. 26-8. 64 
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f) Globulin Fraction 
Weeks 
Mean Values and Range ( %) 
(Number of estimations in brackets) 
I (16) I+F (18) Cu (4) 
20 10.15 10.50 8.62 
7 -10 -12.60 8.06 -13.05 7.72-9.80 
36 12.50 11.50 12. 26 
8.83 -16.37 8.40 -15.05 10.10 -13.60 
PN 8.16 8.10 7. 21 
5.38 -11.40 5.84 -10.50 5.80-8.40 
yGlobulin Fraction 
Mean Values and Range. ( %) 
(Number of estimations in brackets) 
Weeks I (16) I+F (18) Cu (4) 
20 11.63 11.17 12. 98 
9.30-16.8 7.60 -14.40 9.90-16.80 
36 11.23 10.89 11. 54 
8.10 -17.25 8.63 -13.76 7.94 -15.35 
PN 12.39 10. 75 11.62 
8.95-15.7 8.35-15.9 8.10-14.3 
The differences were compared only in the I And I +F groups 
because of the small number of results available in the Cu group. The only: 
significant differences found were in the post -natal specimens when the mean 
values of and y Globulin were significantly higher in the group which 
had been on Iron than in the group which had been on Iron + Folic acid (p.< 0.02) 
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Variations in the Protein Electrophoresis Patterns 
The mean values of the protein fractions in the different groups, 
on the whole, follow the pattern usually described in pregnancy (Mack, 1955 
Brown et al 1959). 
Whiteside (1960) observed that in 50% of his cases, all treated 
with iron from early pregnancy, there was a significant increase in plasma 
volume from the first estimation to a second made between 28 and 36 weeks. 
This did not occur in the other 50% or in the red cell volume of either group. 
Protein electrophoresis showed a variation in the usual pregnancy pattern 
in the group with increased plasma volume. It is usually reported that 
albumin and 0 globulin fall in pregnancy whiled ? 
2, 
and a globulin rise. 
1 
In the cases with increased plasma volume Whiteside found that vC and 
o< globulin fell. 
The results in the present study were inspected and it was found 
that there was marked individual variation of the pattern. Eight of the 16 
women (50 %) in the group on iron showed a fall of 1 and /or globulin 
between the readings at 20 and 36 weeks. This pattern was present in 3 of 
the 18 (17 %) women on iron + folic acid. Plasma and red cell volumes for 
these :patients were extracted and compared with the volumes in women ._ who 













Max 3664 (23) 4441 (11) 
28 -36 2470 -5260 2560 -5860 
28 3444 (22) 3745 (11) 
2160-5650 2560-5860 
36 3346 (21) 3936 (11) 
2160-5260 1940-5430 
40 2937 (12) 3126 (8) 
1910 -5240 2330 -4660 
PN 2330 (23) 2472 (11) 
1850-3560 1770-3710 
Red Cell Volume 
Weeks 
20 




- 1080 -1970 




Max 1778 (2) 2179 (II) 
28 -36 1170 -2790 1340 -3070 
28 1635 (22) 1767 (II) 
900 -2310 1140 -2940 
36 1677 (21) 1961 (II) 
1120 -2790 1180 -3070 
40 1578 (12) 1686 (8) 
1120 -3070 1370 -2260 
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Weeks Normal Atypical 
PN 1271 (23) 1312 (II) 
850-1595 910-1930 
Neither plasma or red cell volume showed any significant 
differences when the comparisons were made between the mean values at 
20, 28, 36 and 40 weeks or eat the post -natal visit. However, when the 
highest value at either 28 or 36 weeks was taken it was found that this 
mean value was significantly higher than the mean value at 20 weeks in the 
atypical group. This applied to both plasma volume and red cell volume. 
Plasma volume, p<0. 01, and red cell volume, p <9.005. In addition the 
comparison of mean maximum values (28 -36 week) between the normaland 
atypical groups showed a higher level for the atypical group of borderline 
significance. Plasma volume p < 0. 05 and redcell volume, p<0.05. 
Maternal Weight Gain. (Vol. 2. p. 105). 
It was possible to estimate maternal weight gain in most of the 
cases as the stated pre -pregnancy weight was available. This was subtracted 
from the last weight in the ante -natal record if this was within two weeks 
of delivery. The weights of the child and the placenta were subtracted from 
this figure to give a reasonable approximation of weight gained by the woman 
during pregnancy. The mean values for the groups I, I +F and Cu were 
compared but no significant differences were found. 
Baby Weights. (Kgms) 
Group Mean Range Standard Error 
I (51)* 3. 340 2. 015 -4. 380 0. 075 
I +F (51) 3. 500 2.709-4.824 0. 078 
Cu (16) 3. 290 2. 580 -4. 086 0. 095 
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* The group on iron included two sets of twins. 
The mean values for the three groups were compared but no 
significant differences were found. 
Placental weights. (Kgms) 
Mean Range Standard Error Group 
I (47) 0. 691 0.430-0.9904 0.021 
I+F (48) 0. 694 O. 200 -I. 150 0.037 
Cu (14) 0. 631 0.454-0.850 0. 061 
* Excluding twin'.placentae. 
No significant differences were found between the mean values 
in the three groups studied. 
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Discus sion 
Expansion of the blood volume would be expected during 
pregnancy because of the increased vascular bed. Enlarged blood 
vessels are found, not only in the uterus and placenta, but also in the 
breasts and in dilated vessels distal to the large pregnant uterus. 
Rovinsky & Jaffin (1966) demonstrated that after 28 weeks the major 
part of the hypervolaemia was distributed to the maternal venous system 
and lower extremities since the central blood volume which represents 
the placenta and uterine vascular bed forms a progressively smaller 
proportion of the total blood volume as pregnancy continues. Size of 
the placental bed is, however, also related to the degree of hypervolaemia. 
Pritchard (1965 b) and Rovinsky and Jaffin (1965) report greater blood 
volume increments in twin pregnancies and the latter authors also found 
a positive correlation between plasma volume increment near term and 
placental mass. 
An increased blood volume is also necessary as part of the 
adaptation needed to carry additional nutrients to the foetus and waste 
products, including heat, away. It is not surprising therefore that Hytten 
& Paintin (1963) find a correlation between the birth weight of the baby and 
maximum plasma increment. These mechanisms come into action 
surprisingly early in pregnancy. Cardiac output and renal flow are both 
increased by 10 weeks (Hamilton, 1949; Palmer & Walker, 1949; Sims and 
Kranz, 1958) and increased plasma volumes are apparent by the end of the 
first trimester (Hytten & Paintin, 1963). 
There is a relationship between plasma volume and red cell volume 
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as is illustrated in cases of severe anaemia. In severe chronic anaemia 
there is usually a modest fall in total blood volume (McMichael et al, 
1943) due to a marked fall in red cell volume which is largely compensated 
by an increased plasma volume (Gibson et al, 1939). A similar pattern 
is found in untreated pernicious anaemia (Gibson, 1939). A very 'recent 
publication of Harrison (1967) describes blood volume changes in severe 
anaemia of pregnancy. He found an increase in plasma volume greater 
than that shown by normal controls which served to maintain total blood 
volume within the normal range. In a few cases with haematocrit readings 
below 14% the plasma volume increase was not enough to replace the red 
cell deficiency and consequently total blood volume was reduced. 
In addition it would seem that a degree of haemodilution is 
desirable in pregnancy as a protective mechanism to the heart (Hamilton 
1950). It therefore seems possible that overstimulation of red cell 
production could be accompanied by a further increase of plasma volume 
to maintain optimum blood viscosity. It has not, however, been demonstrated 
that red cell mass in excess of ¡normal requirements can be produced in 
pregnancy. The work of Dagher et al (1965) although done mainly on men 
would suggest otherwise. These authors consider that red cell volume 
reflects body cell mass and would appear to be 'tailored" to match the 
size of the body cell mass to which the erythrocytes must transport oxygen. 
Red cell volume would be expected to increase in a normal 
pregnant woman in proportion to the increased tissue mass requiring oxygen 
but expansion of theiplasma volume provides the main component of the 
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hypervolaemia. The reasons for this increase would seem to be largely 
mechanical although the precise mechanism is not clear. Neuroreceptors 
which could mediate such a change have not beenfound (Vorys et al, 1963). 
Other factors have been considered. Aldosterone levels are raised in 
pregnancy and hypervolaemia has been shown to accompany primary 
hyperaldersteronism (Biglier and Forsham, 1961). Pritchard (1965b) 
suggested that the growth hormone -like substance in the placenta described 
by Josimovitch & Atwood (1964) may contribute to the hypervolaemia. High 
concentrations of oestrogen and progestogen are present in pregnancy. 
Witten & Bradbury (1951) found that granulosa cell tumours in mice were 
associated with hypervolaemia. Pritchard (1965) referring to his own 
unpublished work mentions that the blood volume can be increased in normal 
adults when large doses of oestrogen are given. The increases however, were 
not nearly as great as those which occur in pregnancy. The presence of a 
foetus is not essential for the development of hypervolaemia as Pritchard 
(1965a) reported increased ,e blood volume of as much as 50% over the 
non pregnant state in some but not all cases of hydatidiform mole. 
One of the earliest attempts to measure the increase in:.blood 
volume in human pregnancy was by Miller, Keith and Rowntree in 1915 
It was not until 1934 that a systematic serial study was made by Dieckmann 
& Wegner using Congo Red. This dye had disadvantages and modern work 
really began with the study of Thomson et al in 1938 in which they used 
Evans blue dye as a tracer. Since that time many studies have been made.; 
In some series plasma volume has been estimated and other. values 
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calculated, making use of haematocrit readings. Since the introduction 
of radioactive tracers it has been possible to make direct estimations of 
red cell volume. The most prominent feature of the published papers on the 
subject is the marked variability of results. The individual range at any week 
of pregnancy studied is very wide. Lowenstein et al (1950) found the change 
in plasma volume to range from -. 4% to + 77% on the non pregnant value 
and Lund (1951) + 14% to + 121 %. Similar variations are found in the work 
on red cell volumes. The average maximum increase ranges from 110 ml 
(Roscoe and Donaldson, 1946) to 560 ml (Werk.c et al, 1948). The most careful 
planned recent work on the subject is from Aberdeen and consists of the 
publications of Hytten & Paintin (1963) on plasma volume and Paintin (1962) 
on red cell volume. These are summarised by Drs. Hytten and Leitch on 
p. 24 of their publication "The Physiology of Human Pregnancy" änd are the 
figures used for comparison with those found in the present investigations. 
The results of the present work are illustrated by scattergrams 
showing the individual readings for blood volume, plasma volume, red cell 
volume and haemoglobin mass (Figs. 15, 16, 17 and 18). On inspection the 
most striking feature is the wide range of individual readings at the different 
weeks of pregnancy. This is not so noticeable when the post -natal readings 
are studied and there is also a much closer grouping in women on iron + folic 
acid. In the non -pregnant state there is close correlation between plasma 
volume and body weight and height, Hytten & Paintin (1963). It is 'possible 
that during pregnancy there is individual variation of uterine size and dilatation 
of maternal blood vessels which would explain this wide range of results. 
Many previous workers have expressed their results as percentage 
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increase on non -pregnant values. For this purpose they have used either 
post -natal values in the same women or non -pregnant controls. Hytten & 
Paintin (1963) have shown that this method is fallacious as the increments 
are a function of the non -pregnant values which will vary with the size 
of the woman. The volume of the increment will also depend to some extent 
on the size of the child. In this investigation it was thought that post -natal 
values in the different groups might vary depending on the treatment given 
during pregnancy. For this reason the patterns of volume behaviour in the 
drawn 
different groups were, once again, to show the percentage variation on the 
20 week levels (Figs. 19, 20.) 
Post natal values in the present study are lower than those given 
by Htten & Leitch. The mean values for all groups are compared below 
with the figures given by these authors and also with the post -natal volumes 
reported by Harrison (1966) in normal Nigerian women: - 
E. B. B. F. E. H. & I.L. K. A. H. 
B. V. 3600 4000 3592 
P. V. 2340 2600 2405 
R.C.V. 1260 1400 1187 
Red cell volume is 35% of the total volume in the present series 
and in the Scottish figures but is slightly less (33 %) in Nigerian women.: 
The lower volumes shown probably reflect the smaller average size of 
Welsh women as compared with. Scottish women. 
There was considerable individual variation of the stage of 
pregnancy at which the maximum volume increments were recorded. This 
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groups studied of doubtful value. The group on iron showed a maximum 
increment for blood volume and red cell volume at 36 weeks and for plasma 
volume at 28 weeks. The maximum increment was at 20 weeks for all 
volumes in the I +F group and at 28 weeks in the Cu group. None of the 
groups showed a continued rise of red cell volume to 40 weeks as shown 
by Hytten & Leitch (1964). This might be due to the smaller number of 
readings available by this stage of pregnancy. 
The diagrammatic patterns of volume behaviour shown in figures 
19 and 20 have been drawn so that the relative behaviour of blood volume, 
plasma volume, red cell volume and haemoglobin mass can be studied 
together in each of the four groups (I, I +F, Cu & Cw. ) 
The group on iron show a pattern of volume changes similar to 
that usually reported. A large part of the volume increase has already 
occured by 20 weeks and there is a continued slight rise to 36 weeks. 
The fall at 40 weeks is rather greater than is shown by Hytten and Leitch. 
Points of interest are the relative fall in plasma volume as the red cell 
volume ineaches its maximum at 36 weeks and also the 'lag' in the increase 
of haemoglobin mass at this time compared with the red cell volume. One 
would have expected a comparàble increase as well haemoglobinated cells 
should have been produced in women on an iron supplement. 
The most interesting pattern is shown by the group on iron + folic 
acid. Maximum increments are reached at 20 weeks and fall through the rest 
of pregnancy. The fall mainly occurs in the plasma volume. Red cell volume 
Fig. 20. Pattern of Volume Changes 
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and haemoglobin mass are very comparable and are reduced only 5% 
by 36 weeks while plasma volume is reduced by 11 %. When Fisher's test 
for combining significance levels from different samples was applied 
to plasma volume it was shown to be significant at the 5% level. In addition 
on inspection of the individual results 15 of the 24 women in the I +F group 
(62 %) showed this pattern of a fall in plasma volume as compared with 7 out 
of 20 women in the group on iron (35 %) and 8 of the 25 women in the combined 
untreated groups (32 %). 
This variation in the usually reported behaviour of blood volume 
in pregnancy is difficult to explain. The Nigerian women studied by Harrison 
(1966) were also taking iron and folic acid and did not behave in this way. 
Additional possible differences between these women and those of 
other groups were investigated. The case records of all of the women in the 
project were studied and it was found that slight to moderate oedema was 
present in the following proportions of women in the different groups:- 
Group Total No. with oedema % 
I 49 14 29 
I +F 51 27 53 
Cu 16 3 19 
Cw 38 18 47 
It is suggested that the high incidence of oedema in the Cw group 
is associated with anaemia. The unexpect finding is that almost twice as 
many women in the group on iron + folic acid showed some degree of oedema 
as in the group on iron only. The maternal weight gain was compared and no 
significant differences were found. Maternal weights and presence or absence 
Fig. 21. Pattern of Volume Changes 
Red Cell Volume and Plasma Volume Related to behaviour of «, and «2 Globulin 
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of oedema were both taken from the clinical records retrospectively. 
In any future work accurate measurements would be necessary. These 
rather rough.: findings suggest the possibility that there is some relationship 
between folic acid metabolism and intra- vascular and extra -vascular fluid 
balance. In cases where serum folate levels were available mean values 
for the pregnancy were compared in women with and without oedema. No 
significant differences were found. 
One further piece of evidence suggests the possibility of a 
relationship between folic acid metabolism, plasma globulins and plasma 
volume. Whiteside (1960) found that increased plasma volumes were 
associated with a fall in and o 2 globulins (these usually rise in p gnancy). 
To investigate this further protein electrophoresis patterns wer e studied. 
16 
Eight of the women (50 %) with results available in the group on iron showed 
a fall incl..). and / or e Z globulin. This is the same incidence as reported by 
Whiteside. His patients were also taking iron. Eighteen women in the I +F 
group had results available and only 3 of these (17 %) showed a fall in a< 
globulins. Plasma and red cell volumes for women with atypical and normal 
globulin patterns were extracted and':a diagrammatic representation of the 
mean values is shown in Figure 21. It will be seen that women with normal 
glcbíllin behaviour show plasma and red cell volume patterns véíty similar 
to those demonstrated in Figure 19 for women on iron + folic acid. 
A simpler explanation is perhaps that of Dr. Victor Herbert 
(personal communication). He suggested that the behaviour of the plasma 
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volume in the I +F group reflected the correction of a latent folic acid 
deficiency which remained uncorrected in the other groups. As has 
already been mentioned in Chapter 3 a proportion of the women in all 
groups entered the investigation at 16 weeks. The mean plasma volume 
for the 15 women who began to take iron + folic acid at 16 weeks is 3535 
ml while in the eight women who did not start until after the first plasma 
volume estimation at 20 weeks it is 4456. Similarly in the gaup on iron 
when divided in this way the mean values are 3478 ml and 4036 ml 
respectively. In this group 10 of the 20 women began to take iron at 16 
weeks. The numbers of patients involved here are small but the figures 
provide some support for Dr. Herberts view that plasma: volume can 
reflect even latent anaemia. 
The patterns of volume changes in the untreated groups have now 
to be considered. The ;,,rrain feature of interest in the pattern shown by 
the Cu group is the close relationship between red cell volume and'plasma 
volume. In addition the relative increase in haemoglobin mass does1'not 
fall below the incl. rease for red cell volume. The peak at 28 weeks is 
pronounced but is due to two high readings which, although within two 
standard errors of the mean have undue weight in the small number of 
results available in this group. It should also be noted that the mean values 
at the post -natal visit in the Cu group are lower than in the treat ed groups. 
Plasma volume is 159 ml lower than in the I +F group and 137 ml lower than 
in the group on iron. The differences in red cell volume are 136 and 120 ml 
and in haemoglobin mass 49 and 53 grammes. The proportion of red cell 
volume in the total blood volume is 34% as compared with 35% in the treated 
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groups. These differences are not significant but suggest that even 
apparently normal women who showed no evidence of anaemia during 
pregnancy are at a slight disadvantage after pregnancy when compared 
with women who received supplements. 
Haemoglobin mass in the Cw group shows a different relationship 
to red cell volume than has been seen in the other gm ups. It is relatively 
much lower and probably reflects increasing hypochromia of red cells. 
The increase in red cell volume at 36 weeks in this group is difficult 
to explain. The mean values are, however, derived from only five readings. 
In general, the range of individual readings is wide with a high 
standard error of the meanin most instances. It is felt, t herefore, 
particularly where few readings are available, that the main value of these 
estimations is in the relationship of red cell volume, haemoglobin mass 
and plasma volume in their re spective groups rather than in the comparison 
of mean values between the groups. 
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Chapter 6. 
Synthesis and Conclusions 
The information gained in this investigation can be considered 
under two headings: - 
1) The effect of iron and folic acid supplements on erythro- 
poeisis and plasma volume. 
2) The relationship between iron, folic acid and vitamin B12. 
1. The Effect of Supplements of Erythropoeisis and Plasma Volume 
A normal woman with adequate iron stores, normal absorption and 
on a good diet would seem to undergo physiological changes during pregnancy 
designed to increase erythropoeisis. Iron stores are utilised and the plasma 
transferrin pool is increased and becomes more active. These changes 
result in better absorption of iron. Increased quantities of folic acid are 
also needed and become available perhaps from increased absorption and 
possibly from utilisation of red cell folate (Grzesiukowicz et al, 1965). The 
body normally contains large stores of vitamin B12 and the rate of absorption 
would seem to be adequate even with the additional burden of pregnancy. 
(Heyssel et al, 1966). 
Under these conditions red cell mass is able to increase to the 
optimum needed for oxygenation of additional tissues. At the same time, there 
is an increase in plasma volume of sufficient amount to supply the increased 
vascular bed, reduce blood viscosity and also nourish and remove waste 
products from the foetus. 
Unfortunately rather less than 30% of pregnant women seem to 
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behave in this way. Seventy to eighty per cent of pregnant women present 
clinically with haemoglobin levels below 12 g /100 ml. It is routine in 
most clinics to give such women iron and in some centres folic acid as 
well. Such women are not necessarily "anaemic" as their red cell volume 
can be within normal limits. The fall in haemoglobin concentration is then 
due to excessive increase of plasma volume. Although in some women 
increased plasma volumes are difficult to explain, the findings in this 
investigation suggest that it can be associated with iron and /or folic acid 
deficiency even if this is not sufficiently severe to depress production of 
red cells. The red cells produced, however, may contain less than the 
optimum amount of haemoglobin. 
Erythropoeisis is stimulated by therapeutic doses of iron in this 
series as was reported by Paintin et al (1966). This is reflected by red 
cell volumes which are in the region of 200 ml higher than in normal untreated 
women (excluding the two exceptionally high readings in the Cu group at 28 
weeks). In the same way, plasma volumes in women on iron become 
progressively greater than the plasma volumes of untreated normal women 
as pregnancy continues. It is suggested that this is a response to the increased 
red cell volume and occurs to preserve the optimum degree of haemodilution 
and thence blood viscosity. 
It is also possible that excessive iron causes a relative deficiency 
of folic acid and that this is reflected by increased plasma volume. There 
are some indications in the present work that this may be mediated by 
alterations in plasma globulin patterns. Further work is required here using 
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more sophisticated methods to study protein fra ctions and also in women 
with folic acid deficiency anaemia of pregnancy. 
When folic acid is given in addition to iron the mean red cell 
and plasma volumes are more comparable to those recorded for normal 
untreated women. It would seem that in some unexplained way the metabolism 
of iron and folic acid are related so that when both are present in comparable 
amounts erythropoeisis is no longer stimulated beyond the requirements of 
the body cell mass. 
2. The relationship between Iron, Folic Acid and Vitamin B12 - 
In pregnancy there is an increased need for iron, folic acid and 
vitamin B12, both to increase the red cell mass of the mother and to supply 
the foetus. Serum iron and serum folate levels vary in relation to food 
intake and so only givenan approximate guide to status in the patient. Total 
Of 
iron binding capacity and % saturation transferrin provide a more reliable 
index of iron status. Recent work (Lawrence, 1967; personal communication) 
suggests that red cell folate levels would have been of more value in the 
case of folic acid but these are not available. 
Normal untreated women in the present investigation show increased 
activity of the transferrin pool as reflected by raised mean values of total 
iron binding capacity and a fall in % saturation. Serum iron levels also fall. 
It is thought that these changes are an indication of the physiological adaptation 
necessary to promote increased absorption and utilisation of iron. Mean 
serum folate levels remain reasonably uniform throughout pregnancy and show 
little change from non pregnant levels in the same patients. Mean serum B12 
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show.ia moderate fall. It is possible that this reflects a physiological 
adaptation due to pregnancy but the reasons for the change and the 
mechanism cannot be explained. 
The addition of therapeutic quantities of iron produce the expected 
increase in serum iron levels but there seems to be a depression of 
activity of the transferrin pool, as, by the end of pregnancy, mean total 
iron binding capacity falls and there is an increase in mean % saturation. 
There is a rather greater fall in mean serum B12 levels and serum folate 
levels fall slightly throughout pregnancy. 
When folic acid is also given raised serum iron levels are still 
found but there seems to be recovery of activity of the transferrin pool. 
This is shown by the continued increase of mean total iron binding capacity 
throughout pregnancy which is associated with lower mean % saturation 
levels than are found in the group on iron. This again suggests that iron 
and folic acid should be present in comparable amounts for optimal 
utilisation of both. Reports of the development of megaloblastosis and 
other evidence of folic acid deficiency, in association with severe iron 
deficiency, support this thesis. The fall in serum folate levels in the 
presence of excessive iron would also seem to indicate an association between 
. iron and folic acid metabolism. 
In the presence of additional iron and folic acid, mean serum B12 
levels show a greater initial rate of fall and a slightly greater number of 
low individual readings are recorded during the pregnancy. The lowest mean 
value, however, is comparable with that seen when iron alone is given. 
-g2- 
It is thought that these slight variations in behaviour of serum B levels 
12 
in the treated groups also indicate that vitamin B12 metabolism is closely 
associated with iron and folate metabolism and that once again there is a 
relative deficiency in one variable as compared with an excess of one or 
both of the others. It is suggested that the changes are less pronounced 
because of the large stores of vitamin B12 normally present in the body. 
Changes in the mean lobe counts in the treated groups would seem 
to suggest that both iron and folic acid have a quantitive effect in increasing 
the rate of maturation in marrow cells. There was little change in the 
mean lobe counts through pregnancy in the normal untreated group. The 
mean value at 20 weeks was, however, significantly lower in the Cu group. 
This may be an indication of initial normality when compared to the treated 
groups. The latter probably included some women with latent deficiency 
of iron and/or folic acid. 
Conclusions 
Iron and folic acid nutrition would seem to be optimal in not more 
than 30% of pregnant women. The modern custom of giving iron supplements 
would be improved by giving folic acid as well to ensure a better metabolic 
balance. The combination is beneficial in themajority of women and was not 
found to be disadvantageous in women who did not need supplements. 
Examination of the haemoglobin concentration is usually the only 
test available in a busy ante -natal clinic to distinguish the small proportion 
of women who do not need supplements from those who would benefit. There 
is no clear distinction between the haemoglobin levels in the two groups by 
the 20th week of pregnancy? but results available earlier in pregnancy suggest 
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that haemoglobin concentrations of less than 13. 0 g /100 ml before 16 
weeks have a close association with latent deficiencies. 
than 
It is probable that smaller doses of iron and folic acid have 
been used in this investigation would be sufficient in most women. 
In the case of folic acid 300 jag/day would be,a safer quantity because of 
the remote possibility of significant vitamin B12 deficiency. 
These observations are not intended to apply to women who 
are anaemic in early pregnancy or who become anaemic by reason of 
metabolic defects or defective absorption. 
Routine supplements of iron and folic acid during pregnancy 
would be of some assistance in protecting women from the minor ailments 
so often associated with chronic anaemia in the later child- bearing years. 
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SUMMARY 
1. Reproduction is a physiological function of the body and one would 
expect normal women without intercurrent disease to remain in good health 
during pregnancy and after delivery. Minor ill health during and after 
child- bearing is common in women until the time of the menopause. This 
is frequently related to chronic anaemia. As a result of such observations 
it is now common practise to give iron, and in some centres folic acid also, 
as a routine supplement to all pregnant women. 
2. A proportion of women will be given supplements unnecessarily or 
in excess of their requirements. It is desirable to know what proportion of 
women do not need additional iron and folic acid and also whether it is possible 
to recognise these women in early pregnancy. It would also be of value to know 
whether women in general benefit as shown by tests made to demonstrate the 
status of iron, folic acid and vitamin B12 nutrition or whether mineral and 
vitamin supplements in excess can cause unexpected metabolic problems. 
3. In this investigation comparisons were made between untreated women, 
women on 194 mg. ferrous sulphate daily and women on 194 mg. ferrous sulphate 
+ 3.4 mg. folic acid daily. Two hundred women, 20 weeks pregnant or less 
entered the investigation and 154 were followed through to the post -natal visit 
6 -8 weeks after delivery. Women were placed in the treatment groups by means 
of randomised lists stratified by age, parity and initial haemoglobin level. Only 
women with haemoglobin levels of more than 10. Og/100 ml at 20 weeks were 
admitted to the investigation. In retrospect this was probably too low and a 
Lower limit of 11.0 g/100 ml would have been preferable. In the same way 
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although the range of age and parity was comparable in the three groups, 
in a physiological study of this sort it would probably have been better to 
have studied women in a smaller age range and of uniform parity. 
4. For the purpose of this communication, results at 20, 28, 36 and 
40 weeks are used together with the results at the post -natal visit. 
Haemoglobin, haematocrit, mean corpuscular haemoglobin concentration, 
serum iron, total iron binding capacity, latent iron binding capacity and 
saturation estimations are available on all women. Blood films were 
also examined in all cases and mean lobe counts made. Serum B12 and 
serum folate estimations are available on half of the women in each 
trea tment group and blood volume, plasma volume, red cell volume and 
haemoglobin mass estimations in the other half. The lists for these 
sub - groups were also randomised. 
5. The results are analysed and discussed in relation to the findings 
reported by previous authors. 
6. The information gained from the various investigations and from 
relevant publications of previous observers is finally synthesised under 
two headings_ 
a) The effect of iron and folic acid supplements on erythropoesis 
and plasma volume. 
b) The relationship between iron, folic acid and vitamin B12 
metabolism. 
7. It is '.concluded that:-- 
a) Iron and folic acid nutrition are optimal in not more than 30% 
of women. 
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b) It is not possible to make a certain identification of all 
women who will benefit from treatment at the 20th week of 
pregnancy but there is some indication that haemoglobin levels 
of less than 13.0 g/100 ml before 16 weeks should be suspect. 
c) The metabolic balance is closer to the normal pattern when 
folic acid is given in addition to iron. 
d) There was no evidence to suggest that iron and folic acid 
had a disadvantageous effect when given unnecessarily. 
e) The observations apply to women with sub - clinical 
deficiencies. It is thought that supplements in these women would 
help in the prevention of mild chronic ill health in the later years 
of their child bearing career. 
f) It is suggested that smaller supplements than are given at 
present would be sufficient in most women. This applies 
particularly to folic acid and 300 jag /day would seem to be an 
optimal dose. 
8. These conclusions are reached on information available at present 
but a number of matters require further elucidation. 
a) It would be useful to repeat this study using smaller quantities 
of iron and folic acid and also to investigate the effect of a small 
vitamin B12 supplement. 
b) There was evidence of a relationship between folic acid, 
plasma volume, serum globulins and intra and extra -vascular fluid 
balance. Further work with careful assessment of oedema and 
maternal weight gain would be of value. A more advanced study of 
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protein globulin fractions is also necessary. 
c) Folic acid seemed to modify the stimulation of erythropoeisis 
caused by iron. This needs to be repeated and if confirmed opens 
a further field for investigation in a study of the complex relationship 
between iron and folic acid metabolism. 
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